<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables v1.3 20210610//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-3.dtd?><?SourceDTD.Version 1.3?><?ConverterInfo.XSLTName jats-oasis2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Appl Environ Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Appl Environ Microbiol</journal-id><journal-id journal-id-type="publisher-id">aem</journal-id><journal-title-group><journal-title>Applied and Environmental Microbiology</journal-title></journal-title-group><issn pub-type="ppub">0099-2240</issn><issn pub-type="epub">1098-5336</issn><publisher><publisher-name>American Society for Microbiology</publisher-name><publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmcid">10746191</article-id><article-id pub-id-type="pmid">38054733</article-id>
<article-id pub-id-type="publisher-id">01211-23</article-id><article-id pub-id-type="doi">10.1128/aem.01211-23</article-id><article-id pub-id-type="publisher-id">aem.01211-23</article-id><article-categories><subj-group subj-group-type="heading"><subject>Genetics and Molecular Biology</subject></subj-group><subj-group subj-group-type="biological-terms"><compound-subject><compound-subject-part content-type="code">environmental-microbiology</compound-subject-part><compound-subject-part content-type="label">Environmental Microbiology</compound-subject-part></compound-subject></subj-group></article-categories><title-group><article-title>Development of a fumonisin-sensitive <italic toggle="yes">Saccharomyces cerevisiae</italic> indicator strain and utilization for activity testing of candidate detoxification genes</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0004-3900-3847</contrib-id><name><surname>Krska</surname><given-names>Tamara</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="cor1" ref-type="corresp"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><email>tamara.krska@boku.ac.at</email></contrib><contrib contrib-type="author"><name><surname>Twaruschek</surname><given-names>Krisztian</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Valente</surname><given-names>Nina</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role></contrib><contrib contrib-type="author"><name><surname>Mitterbauer</surname><given-names>Rudolf</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="pa1" ref-type="author-notes"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role></contrib><contrib contrib-type="author"><name><surname>Moll</surname><given-names>Dieter</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role></contrib><contrib contrib-type="author"><name><surname>Wiesenberger</surname><given-names>Gerlinde</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Berthiller</surname><given-names>Franz</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Adam</surname><given-names>Gerhard</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor2" ref-type="corresp"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><email>gerhard.adam@boku.ac.at</email></contrib><aff id="aff1"><label>1</label><institution-wrap><institution>Department of Applied Genetics and Cell Biology, Institute of Microbial Genetics, University of Natural Resources and Life Sciences, Vienna (BOKU)</institution></institution-wrap>, <city>Tulln</city>, <country>Austria</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution>Austrian Competence Centre for Feed and Food Quality, Safety &#x00026; Innovation, FFoQSI GmbH</institution></institution-wrap>, <city>Tulln</city>, <country>Austria</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution>dsm-firmenich ANH Research Center Tulln</institution></institution-wrap>, <city>Tulln</city>, <country>Austria</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution>Department of Agrobiotechnology, Institute of Bioanalytics and Agro-Metabolomics, IFA-Tulln, University of Natural Resources and Life Sciences, Vienna (BOKU)</institution></institution-wrap>, <city>Tulln</city>, <country>Austria</country></aff></contrib-group><contrib-group><contrib contrib-type="editor"><role>Editor</role><name><surname>Bose</surname><given-names>Arpita</given-names></name><aff><institution-wrap><institution>Washington University</institution></institution-wrap>, <city>St. Louis</city>, <state>Missouri</state>, <country>USA</country></aff></contrib></contrib-group><author-notes><corresp id="cor1">Address correspondence to Tamara Krska, <email xlink:href="mailto:tamara.krska@boku.ac.at">tamara.krska@boku.ac.at</email></corresp><corresp id="cor2">Address correspondence to Gerhard Adam, <email xlink:href="mailto:gerhard.adam@boku.ac.at">gerhard.adam@boku.ac.at</email></corresp><fn fn-type="present-address" id="pa1"><p>Present address: Sandoz GmbH, Kundl, Austria</p></fn><fn fn-type="COI-statement"><p>There is a conflict of interest due to T. Krska and K. Twaruschek being employed by FFoQSI. The initial stages of this work have also been funded by Biomin Holding GmbH (part of dsm-firmenich, employing Wulf-Dieter Moll) and the final stages by FFoQSI GmbH (Austrian Competence Centre for Feed and Food Quality, Safety &#x00026; Innovation, project C30-P12-W03: Toxin Inactivation). IP rights have been transferred to FFoQSI, which filed a patent application (PCT/EP2023/062973).</p></fn></author-notes><pub-date publication-format="electronic" date-type="collection"><month>12</month><year>2023</year></pub-date><pub-date date-type="pub" publication-format="electronic"><day>06</day><month>12</month><year>2023</year></pub-date><pub-date pub-type="pmc-release"><day>06</day><month>12</month><year>2023</year></pub-date><!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.--><volume>89</volume><issue>12</issue><elocation-id>e01211-23</elocation-id><history>
<date date-type="received"><day>13</day><month>7</month><year>2023</year></date>
<date date-type="accepted"><day>20</day><month>10</month><year>2023</year></date>
</history><permissions><copyright-statement>Copyright &#x000a9; 2023 Krska et al.</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Krska et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2023-12-06"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="aem.01211-23.pdf"/><abstract abstract-type="primary"><title>ABSTRACT</title><p>Fumonisins, produced mainly by various <italic toggle="yes">Fusarium</italic> species, are sphinganine-analog mycotoxins and potent inhibitors of ceramide synthases in animals, plants, and other eukaryotes, leading to toxicity and programmed cell death. Wild-type baker&#x02019;s yeast is naturally highly resistant to fumonisin B<sub>1</sub> (FB1); on rich medium, it tolerates more than 1,000 &#x000b5;M. We report the construction of a fumonisin-sensitive <italic toggle="yes">Saccharomyces cerevisiae</italic> strain with six disrupted genes: <italic toggle="yes">SNQ2</italic>, <italic toggle="yes">PDR12</italic>, and <italic toggle="yes">YOR1</italic>, coding for ATP-binding cassette transporters involved in active efflux; <italic toggle="yes">CKA2</italic>, encoding casein kinase II, regulating ceramide synthase activity by phosphorylation; and <italic toggle="yes">LCB3</italic> and <italic toggle="yes">VPS51</italic>, encoding proteins involved in the biosynthesis and recycling of sphingolipid precursors, respectively. The constructed FB1-sensitive strain YTKT33 was tested on complex yeast extract-peptone-dextrose (YPD) and synthetic complete medium alongside the wild-type strain and strains with only three (YRU74) or five (YRU94ML) disrupted genes. YTKT33, exhibiting full growth inhibition at a concentration below 5 &#x000b5;M FB1 on synthetic complete agar lacking uracil (SC-URA), was used as a host for heterologous expression of previously reported fumonisin detoxification genes. Transformants expressing either the <italic toggle="yes">Sphingopyxis fumD</italic> esterase, which removes removing tricarballylic acid side chains, or an <italic toggle="yes">Aspergillus</italic> amine oxidase, which converts the amino- to a keto-group, can grow at FB1 concentrations inhibitory for transformants containing the empty vector. YTKT33 was inhibited by other type B fumonisins (B<sub>2</sub>, B<sub>3</sub>, B<sub>4</sub>) at concentrations very similar to FB1, allowing rapid evaluation of total fumonisin toxicity in crude fungal extracts.</p><sec><title>IMPORTANCE</title><p>Fumonisins can cause diseases in animals and humans consuming <italic toggle="yes">Fusarium</italic>-contaminated food or feed. The search for microbes capable of fumonisin degradation, or for enzymes that can detoxify fumonisins, currently relies primarily on chemical detection methods. Our constructed fumonisin B1-sensitive yeast strain can be used to phenotypically detect detoxification activity and should be useful in screening for novel fumonisin resistance genes and to elucidate fumonisin metabolism and resistance mechanisms in fungi and plants, and thereby, in the long term, help to mitigate the threat of fumonisins in feed and food.</p></sec></abstract><kwd-group><title>KEYWORDS</title><kwd>bioassay</kwd><kwd>mycotoxin detoxification</kwd><kwd>bioindicator</kwd><kwd><italic toggle="yes">S. cerevisiae</italic></kwd></kwd-group><funding-group specific-use="FundRef"><award-group award-type="grant" id="award-1"><funding-source>
<institution-wrap><institution>Biomin (BIOMIN Holding GmbH)</institution></institution-wrap>
</funding-source><principal-award-recipient>
<name><surname>Moll</surname><given-names>Dieter</given-names></name>
</principal-award-recipient></award-group><award-group award-type="grant" id="award-2"><funding-source>
<institution-wrap><institution>FFoQSi GmbH</institution></institution-wrap>
</funding-source><principal-award-recipient>
<name><surname>Krska</surname><given-names>Tamara</given-names></name>
<name><surname>Twaruschek</surname><given-names>Krisztian</given-names></name>
</principal-award-recipient></award-group><award-group award-type="grant" id="award-3"><funding-source>
<institution-wrap><institution>Austrian Science Fund (FWF)</institution></institution-wrap>
</funding-source><award-id>P33011</award-id><principal-award-recipient>
<name><surname>Wiesenberger</surname><given-names>Gerlinde</given-names></name>
<name><surname>Berthiller</surname><given-names>Franz</given-names></name>
</principal-award-recipient></award-group></funding-group><counts><count count="1" count-type="supplementary-material"/><count count-type="authors" count="8"/><fig-count count="5"/><table-count count="2"/><ref-count count="54"/><page-count count="14"/><word-count count="8784"/></counts><custom-meta-group><custom-meta><meta-name>cover-date</meta-name><meta-value>December 2023</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p>Fumonisins are a class of toxicologically relevant <italic toggle="yes">Fusarium</italic> secondary metabolites that are produced predominantly by members of the <italic toggle="yes">Fusarium fujikuroi</italic> species complex (<xref rid="B1" ref-type="bibr">1</xref>). Particularly important are <italic toggle="yes">Fusarium verticillioides</italic>, <italic toggle="yes">Fusarium proliferatum</italic>, and other species (<italic toggle="yes">Fusarium temperatum</italic>, <italic toggle="yes">Fusarium subglutinans</italic>) on maize in warmer climates, such as in Africa (<xref rid="B2" ref-type="bibr">2</xref>), where fumonisin was discovered. Fumonisin production and contamination also occur in southern parts of Europe, not only on maize but also in wheat and barley (<xref rid="B3" ref-type="bibr">3</xref><xref rid="B4" ref-type="bibr">&#x02013;</xref><xref rid="B5" ref-type="bibr">5</xref>). Fumonisin-producing <italic toggle="yes">Fusarium proliferatum</italic> can also infect rice (<xref rid="B6" ref-type="bibr">6</xref>), where fumonisin production is a virulence factor in rice spikelet rot disease (<xref rid="B7" ref-type="bibr">7</xref>). While fumonisin production contributes to virulence in maize seedlings (<xref rid="B8" ref-type="bibr">8</xref>), it is dispensable for the ability to cause maize ear rot (<xref rid="B9" ref-type="bibr">9</xref>). Climate change seems to increase the previously rather negligible threat of fumonisin contamination in central Europe (<xref rid="B10" ref-type="bibr">10</xref>).</p><p>Fumonisins are sphinganine-analog mycotoxins with a sphinganine-like backbone structure (<xref rid="B11" ref-type="bibr">11</xref>). They target ceramide synthases (very-long-chain fatty acyl-CoA:sphingoid base <italic toggle="yes">N</italic>-acyltransferases) of animals (<xref rid="B12" ref-type="bibr">12</xref>), plants (<xref rid="B13" ref-type="bibr">13</xref>) and fungi and can trigger programmed cell death in animal cells and plant cells (<xref rid="B14" ref-type="bibr">14</xref><xref rid="B15" ref-type="bibr">&#x02013;</xref><xref rid="B16" ref-type="bibr">16</xref>).</p><p>To characterize the toxicity of fumonisins and to develop mitigation strategies, mostly chemical assay methods, requiring expensive equipment, are used since previously established bioassays for fumonisin toxicity have shortfalls. Highly purified toxin preparations are needed for mammalian cells cultured <italic toggle="yes">in vitro</italic> to avoid the unspecific toxic effects of other metabolites co-occurring in crude toxin extracts. The reported susceptibility of different human and animal cell lines is quite variable. The effective concentrations ranged mainly from 10 to 100 &#x000b5;M (<xref rid="B17" ref-type="bibr">17</xref>). The IC<sub>50</sub> value for primary rat hepatocytes was reported to be 2,000 &#x000b5;M (<xref rid="B18" ref-type="bibr">18</xref>), while human HepG2 cells are more sensitive, with an IC<sub>50</sub> value of 399 &#x000b5;M (<xref rid="B19" ref-type="bibr">19</xref>). Plants are typically very sensitive; e.g., <italic toggle="yes">Arabidopsis</italic> seed germination and root development are already strongly inhibited by 1 &#x000b5;M fumonisin B<sub>1</sub> (FB1) (<xref rid="B20" ref-type="bibr">20</xref>). However, such bioassays are rather time-consuming (e.g., requiring a 10-day observation period). Duckweed (<italic toggle="yes">Lemna minor</italic>) growth inhibition by 40 &#x000b5;M of fumonisin metabolites over a 5-day period was used to investigate the structure-activity relationship of different fumonisins and metabolites (<xref rid="B21" ref-type="bibr">21</xref>). Similarly, labor-intensive and low-throughput whole-animal test systems were described. For instance, a 4-day incubation period was needed to observe the death or disintegration of <italic toggle="yes">Hydra attenuata</italic> during exposure to 150 &#x000b5;g/mL (~208 &#x000b5;M) FB1 (<xref rid="B22" ref-type="bibr">22</xref>). Similarly, microscopic observation of non-motile or dead brine shrimp (<italic toggle="yes">Artemia salina</italic>) yielded IC<sub>50</sub> values for FB1 ranging from 1.7 &#x000b5;M (48 h) to about 10 &#x000b5;M after 24 h (<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B24" ref-type="bibr">24</xref>).</p><p>Adding detoxification enzymes to fumonisin-contaminated feed commodities (<xref rid="B25" ref-type="bibr">25</xref>) or expressing heterologous detoxification genes already in transgenic plants (<xref rid="B26" ref-type="bibr">26</xref>) are possible strategies to counteract and reduce mycotoxin contamination. However, testing enzyme activity <italic toggle="yes">in vitro</italic> is a major bottleneck in the development of such agents. As of now, <italic toggle="yes">in vitro</italic> efficacy is verified through the determination of the detoxified products [e.g., hydrolyzed FB1 (HFB1)], which requires costly and laborious liquid chromatography-mass spectrometry (LC-MS). Since little is known about fumonisin metabolism in plants, useful endogenous detoxification genes may exist that could be selected by breeders or manipulated by gene editing&#x02014;the search is ongoing. To the best of our knowledge, none of the previously mentioned test organisms can serve as convenient hosts for the expression and high-throughput screening of potential candidate detoxification genes. We therefore set out to engineer <italic toggle="yes">Saccharomyces cerevisiae</italic> as an indicator organism for monitoring the toxicity of fumonisins and to phenotypically detect and test expressed detoxification enzymes.</p></sec><sec sec-type="results" id="s2"><title>RESULTS</title><sec id="s2-1"><title>Strain development with a crude extract containing fumonisins</title><p>Wild-type <italic toggle="yes">Saccharomyces cerevisiae</italic> is highly suited as a host for heterologous gene expression and for monitoring the toxicity of various substances on agar media or in liquid culture on microtiter plates. Yet, <italic toggle="yes">S. cerevisiae</italic> is highly resistant to many compounds, including FB1. To save costly pure FB1 during our initial characterization and strain improvement, we used a crude extract containing fumonisins, which was prepared from maize cultures inoculated with various <italic toggle="yes">Fusarium</italic> strains (see Materials and Methods), with an FB1 content of 3,180 mg/L as determined by LC-MS/MS. Based on this concentration value, the &#x0201c;wild-type&#x0201d; laboratory strain YPH500 (see <xref rid="T1" ref-type="table">Table 1</xref> for relevant genotype and reference) tolerated more than 1,000 &#x000b5;M on rich medium (yeast extract-peptone-dextrose, YPD) (<xref rid="F1" ref-type="fig">Fig. 1A and C</xref>) and more than 300 &#x000b5;M on synthetic complete (SC) medium (<xref rid="F1" ref-type="fig">Fig. 1B and D</xref>). As it has been reported that the ATP-binding cassette (ABC) transporter <italic toggle="yes">YOR1</italic> (Yeast Oligomycin Resistance) is involved in fumonisin resistance (<xref rid="B27" ref-type="bibr">27</xref>), we generated and tested strains that combined <italic toggle="yes">yor1</italic> with mutations of other ABC transporters that were implicated in mediating resistance to charged compounds (<xref rid="B28" ref-type="bibr">28</xref>). We generated all double mutants and the triple mutant with the genes <italic toggle="yes">SNQ2</italic> (Sensitivity to 4-NitroQuinoline-N-oxide) and <italic toggle="yes">PDR12</italic> (Pleiotropic Drug Resistance), and continued strain improvement with the triple mutant YRU74 (see <xref rid="T1" ref-type="table">Table 1</xref> for strain genotypes). This strain had reduced FB1 resistance both on YPD and SC medium compared to wild-type on solid agar plates (<xref rid="F1" ref-type="fig">Fig. 1A and B</xref>). We also tested growth in liquid media in microtiter plates, and here (<xref rid="F1" ref-type="fig">Fig. 1C and D</xref>) resistance was lower.</p><fig position="float" fig-type="figure" id="F1"><label>FIG 1</label><caption><p>Growth inhibition of yeast by a crude fumonisin-containing extract (&#x0201c;crude FB1&#x0201d;) on solid and in liquid media. The wild-type yeast laboratory strain YPH500 and three derived multi-deletion strains YRU74 (triple ABC transporter mutant, <italic toggle="yes">yor1 pdr12 snq2</italic>), YRU94ML (<italic toggle="yes">yor1 pdr12 snq2</italic> plus <italic toggle="yes">cka2</italic> and <italic toggle="yes">lcb3</italic>), and YTKT33 (<italic toggle="yes">yor1 pdr12 snq2 cka2 lcb3</italic> plus <italic toggle="yes">vps51</italic>) were grown in complex (YPD) and synthetic (SC) media overnight and rediluted to an OD<sub>600</sub> of 0.1 in the morning. After reaching (OD<sub>600</sub> &#x0003e;0.3), they were diluted again for spotting on (<bold>A</bold>) YPD and (<bold>B</bold>) SC plates containing crude FB1, as indicated. (<bold>C</bold> and <bold>D</bold>) The inoculum was pipetted into a 96-well microtiter plate with different concentrations of crude FB1 and put into an incubator, where the absorbance at OD<sub>600</sub> was measured after 24 h. At least three replicates were used for each strain. On the x-axis, the graph shows the final FB1 concentration that the strains were exposed to, while the y-axis shows the inhibition of growth in % compared to each strain growing without exposure to FB1. The standard deviation was calculated for the replicates and displayed in the error bars.</p></caption><graphic xlink:href="aem.01211-23.f001" position="float"/></fig><table-wrap position="float" id="T1"><label>TABLE 1</label><caption><p>Yeast strains used or generated in this study</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th align="left" valign="bottom" colspan="1" rowspan="1">Name</th><th align="left" valign="bottom" colspan="1" rowspan="1">Derived from/alteration: plasmid (primers)</th><th align="left" valign="bottom" colspan="1" rowspan="1">Genotype</th></tr></thead><tbody><tr><td align="left" valign="bottom" colspan="1" rowspan="1">YPH499</td><td align="left" valign="bottom" colspan="1" rowspan="1">Wild-type lab strain</td><td align="left" valign="bottom" colspan="1" rowspan="1"><italic toggle="yes">MATa ura3-52 lys2-801 ade2-101 trp1-&#x00394;63 his3-</italic>&#x00394;<italic toggle="yes">200 leu2-</italic>&#x00394;<italic toggle="yes">1</italic></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">YPH500</td><td align="left" valign="bottom" colspan="1" rowspan="1">Wild-type lab strain</td><td align="left" valign="bottom" colspan="1" rowspan="1"><italic toggle="yes">MAT&#x003b1; ura3-52 lys2-801 ade2-101 trp1-</italic>&#x00394;<italic toggle="yes">63 his3-</italic>&#x00394;<italic toggle="yes">200 leu2-</italic>&#x00394;<italic toggle="yes">1</italic></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">YYM5</td><td align="left" valign="bottom" colspan="1" rowspan="1">YPH500/pYM25, FOA</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<italic toggle="yes">MAT&#x003b1; snq2::hisG</italic>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">YRE106</td><td align="left" valign="bottom" colspan="1" rowspan="1">YPH499/pYM63</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<italic toggle="yes">MATa pdr12::hisG-URA3-hisG</italic>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">YRU75</td><td align="left" valign="bottom" colspan="1" rowspan="1">YRE106 FOA</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<italic toggle="yes">MATa pdr12::hisG</italic>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">YZGA456</td><td align="left" valign="bottom" colspan="1" rowspan="1">YPH499 pDK30</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<italic toggle="yes">MATa yor1::hisG-URA3-hisG</italic>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">YZGA494</td><td align="left" valign="bottom" colspan="1" rowspan="1">YPH499 pDK30, FOA</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<italic toggle="yes">MATa yor1::hisG</italic>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">YRE108</td><td align="left" valign="bottom" colspan="1" rowspan="1">YMM5/pYM63</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<italic toggle="yes">MAT&#x003b1; snq2::hisG pdr12::hisG-URA3-hisG</italic>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">YZGA538</td><td align="left" valign="bottom" colspan="1" rowspan="1">YRE108, FOA</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<italic toggle="yes">MAT&#x003b1; snq2::hisG pdr12::hisG</italic>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">YTKT34</td><td align="left" valign="bottom" colspan="1" rowspan="1">YYM5 pDK30</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<italic toggle="yes">MAT&#x003b1; snq2::hisG yor1::hisG-URA3-hisG</italic>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">YTKT35</td><td align="left" valign="bottom" colspan="1" rowspan="1">YRU75/pDK30</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<italic toggle="yes">MATa pdr12:hisG yor1::hisG-URA3-hisG</italic>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">YTKT60</td><td align="left" valign="bottom" colspan="1" rowspan="1">YTKT34, FOA</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<italic toggle="yes">MAT&#x003b1; snq2::hisG yor1::hisG</italic>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">YTKT61</td><td align="left" valign="bottom" colspan="1" rowspan="1">YTKT35, FOA</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<italic toggle="yes">MAT&#x003b1; pdr12::hisG yor1::hisG</italic>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">YZGA1208</td><td align="left" valign="bottom" colspan="1" rowspan="1">YZGA538/pDK30</td><td align="left" valign="bottom" colspan="1" rowspan="1">MAT&#x003b1; <italic toggle="yes">snq2::hisG pdr12::hisG yor1::hisG-URA3-hisG</italic></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">YRU74</td><td align="left" valign="bottom" colspan="1" rowspan="1">YZGA1208, FOA</td><td align="left" valign="bottom" colspan="1" rowspan="1">MAT&#x003b1; <italic toggle="yes">snq2::hisG pdr12::hisG yor1::hisG</italic></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">YRU81</td><td align="left" valign="bottom" colspan="1" rowspan="1">YRU74/pUG72 (dcka2-FW + dcka2 RV)</td><td align="left" valign="bottom" colspan="1" rowspan="1">MAT&#x003b1; <italic toggle="yes">snq2::hisG pdr12::hisG yor1::hisG cka2</italic>&#x00394;<italic toggle="yes">::loxP-KlURA3-loxP</italic></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">YRU83</td><td align="left" valign="bottom" colspan="1" rowspan="1">YRU74/pUG72 (dlcb3-FW + dlcb3 RV)</td><td align="left" valign="bottom" colspan="1" rowspan="1">MAT<italic toggle="yes">&#x003b1; snq2::hisG pdr12::hisG yor1::hisG lcb3</italic>&#x00394;<italic toggle="yes">::loxP-KlURA3-loxP</italic></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">YRU93</td><td align="left" valign="bottom" colspan="1" rowspan="1">YRU83/pUG73 (dcka2-FW + dcka2 RV)</td><td align="left" valign="bottom" colspan="1" rowspan="1"><italic toggle="yes">MAT&#x003b1; snq2::hisG pdr12::hisG yor1::hisG lcb3</italic>&#x00394;<italic toggle="yes">::loxP-KlURA3-loxP cka2</italic>&#x00394;<italic toggle="yes">::loxP-KlLEU2-loxP</italic></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">YRU94</td><td align="left" valign="bottom" colspan="1" rowspan="1">YRU81/pUG73 (dlcb3-FW + dlcb3 RV)</td><td align="left" valign="bottom" colspan="1" rowspan="1"><italic toggle="yes">MAT&#x003b1; snq2::hisG pdr12::hisG yor1::hisG cka2</italic>&#x00394;<italic toggle="yes">::loxP-KlURA3-loxP lcb3</italic>&#x00394;<italic toggle="yes">::loxP-KlLEU2-loxP</italic></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">YRU94*</td><td align="left" valign="bottom" colspan="1" rowspan="1">YRU94 from YPG, red on YPD</td><td align="left" valign="bottom" colspan="1" rowspan="1"><italic toggle="yes">MAT&#x003b1; snq2::hisG pdr12::hisG yor1::hisG cka2</italic>&#x00394;<italic toggle="yes">::loxP-KlURA3-loxP lcb3</italic>&#x00394;<italic toggle="yes">::loxP-KlLEU2-loxP</italic></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">YRU94ML-A</td><td align="left" valign="bottom" colspan="1" rowspan="1">YRU94* pOS4a ADE+/YPGAL</td><td align="left" valign="bottom" colspan="1" rowspan="1"><italic toggle="yes">MAT&#x003b1; snq2::hisG pdr12::hisG yor1::hisG cka2</italic>&#x00394;::<italic toggle="yes">loxP lcb3</italic>&#x00394;<italic toggle="yes">::loxP</italic> [pOS4a: <italic toggle="yes">ADE2-P<sub>GAL1</sub>-Cre</italic>]</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">YRU94ML</td><td align="left" valign="bottom" colspan="1" rowspan="1">YRU94ML ade2</td><td align="left" valign="bottom" colspan="1" rowspan="1"><italic toggle="yes">MAT&#x003b1; snq2::hisG pdr12::hisG yor1::hisG cka2</italic>&#x00394;<italic toggle="yes">::loxP lcb3</italic>&#x00394;<italic toggle="yes">::loxP</italic></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">YTKT1</td><td align="left" valign="bottom" colspan="1" rowspan="1">YRU94ML, YPGal</td><td align="left" valign="bottom" colspan="1" rowspan="1"><italic toggle="yes">MAT&#x003b1; snq2::hisG pdr12::hisG yor1::hisG cka2</italic>&#x00394;<italic toggle="yes">::loxP lcb3</italic>&#x00394;<italic toggle="yes">::loxP vps51</italic>&#x00394;<italic toggle="yes">::loxP-KlLEU2-loxP</italic></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">YTKT33</td><td align="left" valign="bottom" colspan="1" rowspan="1">YTKT1 pBS49, YPGal, plasmid loss</td><td align="left" valign="bottom" colspan="1" rowspan="1"><italic toggle="yes">MAT&#x003b1; snq2::hisG pdr12::hisG yor1::hisG cka2</italic>&#x00394;<italic toggle="yes">::loxP lcb3</italic>&#x00394;<italic toggle="yes">::loxP vps51</italic>&#x00394;<italic toggle="yes">::loxP</italic></td></tr></tbody></table></table-wrap><p>Since the resistance level of YRU74 was still unacceptably high, requiring concentrations of FB1 exceeding naturally occurring levels, we next inactivated the <italic toggle="yes">CKA2</italic> gene, encoding one of the catalytic subunits (alpha&#x02032;) of casein kinase 2. It has been reported that such a mutant had 3&#x02013;4&#x000d7; reduced ceramide synthase activity and reduced resistance to FB1 (<xref rid="B29" ref-type="bibr">29</xref>). We have furthermore knocked out <italic toggle="yes">LCB3</italic>, encoding one of the two long-chain base-1-phosphate phosphatases (paralog <italic toggle="yes">YSR3</italic>), which are needed for the utilization of exogenous long-chain base phosphates present in rich medium. The <italic toggle="yes">cka2 lcb3</italic> double mutant YRU94 initially segregated small and large colonies upon revival from &#x02212;80&#x000b0;C stocks, so a stable respiration-competent clone was selected on YPG, which also formed stable red colonies on YPD, indicating an unimpaired respiration needed for accumulation of the red pigment in adenine-requiring <italic toggle="yes">ade2</italic> mutants. Transformation markers (<italic toggle="yes">LEU2</italic> and <italic toggle="yes">URA3</italic>) were removed from this strain, designated as YRU94*, using plasmid pOS4a (<italic toggle="yes">ADE2 GAL1-Cre</italic>), resulting in YRU94ML-A (ura<sup>&#x02212;</sup> and leu<sup>&#x02212;</sup> but still ADE<sup>+</sup>). After the loss of the pOS4a plasmid, the strain YRU94ML was obtained, which clearly exhibited an over fivefold increase in sensitivity toward FB1 as compared to the <italic toggle="yes">yor1 snq2 pdr12</italic> parental strain (<xref rid="F1" ref-type="fig">Fig. 1C</xref>).</p><p>To further reduce FB1 resistance, we also disrupted <italic toggle="yes">VPS51</italic> (Vacuolar Protein Sorting), a gene encoding a component of the Golgi-associated retrograde protein complex. Endosome-to-Golgi retrograde vesicular transport allows recycling of complex sphingolipids (<xref rid="B30" ref-type="bibr">30</xref>), which would otherwise be degraded using the default pathway in the vacuole. The reduced sensitivity of the strain with the additional <italic toggle="yes">vps51</italic> mutation to FB1 is evident from <xref rid="F1" ref-type="fig">Fig. 1C</xref> (strain grown in liquid YPD) and in the spotting experiment with purified FB1 (<xref rid="F2" ref-type="fig">Fig. 2</xref>), where strain YTKT33 (<italic toggle="yes">yor1 snq2 pdr12 cka2 lcb3 vps51</italic>) is more sensitive than its precursor YRU94ML with wild-type <italic toggle="yes">VPS51</italic> both in YPD liquid culture (<xref rid="F2" ref-type="fig">Fig. 2C</xref>) and on YPD plates (<xref rid="F2" ref-type="fig">Fig. 2A</xref>).</p><fig position="float" fig-type="figure" id="F2"><label>FIG 2</label><caption><p>Sensitivity testing with pure FB1. For strain genotypes, refer to <xref rid="F1" ref-type="fig">Fig. 1</xref> or <xref rid="T1" ref-type="table">Table 1</xref>. Growth inhibition of yeast by a 98% pure FB1 stock on solid and liquid media. The wild-type yeast laboratory strain YPH500 and three derived multi-deletion strains YRU74 (triple ABC transporter mutant, <italic toggle="yes">yor1 pdr12 snq2</italic>), YRU94ML (<italic toggle="yes">yor1 pdr12 snq2</italic> plus <italic toggle="yes">cka2</italic> and <italic toggle="yes">lcb3</italic>), and YTKT33 (<italic toggle="yes">yor1 pdr12 snq2 cka2 lcb3</italic> plus <italic toggle="yes">vps51</italic>) were grown in complex (YPD) and synthetic (SC) media overnight and rediluted to an OD<sub>600</sub> of 0.1 in the morning. After reaching OD<sub>600</sub> &#x0003e;0.3, they were diluted again for spotting on (<bold>A</bold>) YPD and (<bold>B</bold>) SC plates containing crude FB1, as indicated. (<bold>C and D</bold>) Inoculum was pipetted into a 96-well microtiter plate with different concentrations of pure FB1 and put into an incubator, where the absorbance at OD<sub>600</sub> was measured after 24 h. At least three replicates were used for each strain.</p></caption><graphic xlink:href="aem.01211-23.f002" position="float"/></fig></sec><sec id="s2-2"><title>Testing the constructed strains with purified FB1</title><p>The constructed strains were subsequently exposed to media spiked with purified, commercially available FB1 (&#x0003e;98% purity, Fermentek). Compared to <xref rid="F1" ref-type="fig">Fig. 1</xref>, in which only crude fumonisin extracts were used, it is evident in <xref rid="F2" ref-type="fig">Fig. 2</xref> that higher levels of the pure toxin are needed to achieve a similar degree of inhibition. One obvious explanation is that the crude extract contains other intermediates of FB1 synthesis, such as fumonisins B<sub>2</sub> (FB2), B<sub>3</sub> (FB3), and B<sub>4</sub> (FB4), and possibly additionally other forms, such as non-toxic forms (e.g., <italic toggle="yes">N</italic>-acetylated fumonisin A), that might be hydrolyzed and reactivated by the yeast. Yet, no fumonisin A metabolites were detected by LC-MS/MS in the crude extract, and later results (see below) indicate that the response to FB2, FB3, and FB4 was similar to FB1 (see Fig. 4).</p><p>The different behavior of the mutants in the two media is also of interest. While on SC medium, YRU94ML behaved similar to YTKT33 (<xref rid="F2" ref-type="fig">Fig. 2B and D</xref>), on the rich medium, the latter strain was far more susceptible, indicating that components (sphingolipid metabolites not present in SC medium but presumably in the yeast extract in YPD) could reduce fumonisin toxicity in a <italic toggle="yes">VPS51</italic>-dependent manner.</p></sec><sec id="s2-3"><title>Dose-response of strain YTKT33 to B-type fumonisins in liquid synthetic medium</title><p>To determine the inhibition characteristics of different B-type fumonisins [which differ in the hydroxylation pattern; for review, see reference (<xref rid="B31" ref-type="bibr">31</xref>)], we obtained high-purity FB1, FB2, FB3, and FB4 and tested their potency to inhibit the growth of yeast strain YTKT33 in liquid SC medium in microtiter plates. The inhibition of strain YTKT33 upon exposure to fumonisins B<sub>2</sub>, B<sub>3</sub>, and B<sub>4</sub> was similar to the inhibition by FB1 (see <xref rid="F3" ref-type="fig">Fig. 3</xref>).</p><fig position="float" fig-type="figure" id="F3"><label>FIG 3</label><caption><p>Growth inhibition of YTKT33 in microtiter plates in SC medium by B-type fumonisins FB1-FB4. The sensitive yeast strain YTKT33 was grown in SC medium and exposed to different concentrations of FB1, FB2, FB3, and FB4. Strain inoculum was pipetted into a microtiter well plate with 0.6<sup>N</sup> dilutions of the respective fumonisins. After 24 h at 30&#x000b0;C, the optical density at 600 nm (OD<sub>600</sub>) was measured to monitor growth. The blank (medium without yeast) was subtracted from the measured OD<sub>600</sub> values. Means and standard deviations were calculated for four replicates each, as depicted in the error bars of the graphs.</p></caption><graphic xlink:href="aem.01211-23.f003" position="float"/></fig><p>As shown in <xref rid="F3" ref-type="fig">Fig. 3</xref>, the IC<sub>50</sub> values for the four tested fumonisins, FB1, FB2, FB3, and FB4, were all observed to be between 24 and 26 &#x000b5;M. The relative composition of the different compounds in the extract can be variable depending on the <italic toggle="yes">Fusarium</italic> strain and harvesting time, but due to the similar dose-response, the toxicity reflects the sum of all B-type fumonisins. The inhibitory concentrations for YTKT33 obtained in liquid SC culture (in microtiter plates with limited aeration in still cultures) were clearly higher than the inhibitory concentrations observed for the empty vector transformant in spottings carried out on solid synthetic complete media lacking uracil (SC-URA, see <xref rid="F4" ref-type="fig">Fig. 4</xref>).</p><fig position="float" fig-type="figure" id="F4"><label>FIG 4</label><caption><p>Growth of YTKT33-derived strains on URA-dropout SC agar media containing increasing concentrations of FB1 carrying either the empty expression vector pYes2-P<sub>TEF1</sub> (negative control) or expressing one of the following genes: <italic toggle="yes">FUM18</italic> (ceramide synthase from the <italic toggle="yes">F. verticillioides</italic> fumonisin cluster, positive control), <italic toggle="yes">FumD</italic> (<italic toggle="yes">Sphingopyxis</italic> fumonisin carboxylesterase <italic toggle="yes">FumD</italic>), <italic toggle="yes">FumD_noL</italic> (<italic toggle="yes">FumD</italic> lacking the N-terminal secretion signal), and AspAmOx (<italic toggle="yes">Aspergillus</italic> amine oxidase). Three dilutions of the transformed YTKT33 strain were spotted for each culture (OD<sub>600</sub> = 0.1, 0.01, and 0.001).</p></caption><graphic xlink:href="aem.01211-23.f004" position="float"/></fig></sec><sec id="s2-4"><title>Heterologous expression of fumonisin detoxification genes</title><p>Strain YTKT33 is growing slower than the YPH500 precursor strain. Alterations in sphingolipids have been reported to negatively affect heat shock resistance (<xref rid="B32" ref-type="bibr">32</xref>). However, YTKT33 is robust and easily transformable with the standard lithium transformation protocol, which includes a heat shock treatment. We utilized the strain as a host to express candidate fumonisin resistance genes. The empty vector pYes2-P<sub>TEF1</sub> was used in a previous study to express candidate ceramide synthases from a fumonisin-producing <italic toggle="yes">F. verticillioides</italic> strains behind the constitutive <italic toggle="yes">TEF1</italic> promoter (<xref rid="B33" ref-type="bibr">33</xref>). In the aforementioned study, evidence was provided that the <italic toggle="yes">FvFUM18</italic> gene, located in the fumonisin biosynthetic cluster, codes for an insensitive ceramide synthase providing fumonisin self-resistance (<xref rid="B33" ref-type="bibr">33</xref>). The empty vector and the <italic toggle="yes">FUM18</italic> expression vector were used as negative and positive controls in our study. As evident from <xref rid="F4" ref-type="fig">Fig. 4</xref>, the lowest tested fully inhibitory concentration is clearly below 5 &#x000b5;M FB1, at approx. 2.5 &#x000b5;M FB1, which is about 10-fold lower than the IC<sub>50</sub> in liquid SC medium in microtiter plates. Plasmid-based expression of <italic toggle="yes">FUM18</italic> in YTKT33 results in an approximately fourfold increase in resistance, up to 10 &#x000b5;M FB1.</p><p>In addition, we expressed two enzymes altering the chemical structures of fumonisin B<sub>1</sub>, leading to its detoxification. First, we expressed the <italic toggle="yes">Sphingopyxis macrogoltabida</italic> MTA144 <italic toggle="yes">fumD</italic> gene (<xref rid="B34" ref-type="bibr">34</xref>), which encodes a periplasmic secreted carboxylesterase that removes the tricarballylic acid side chains of fumonisins and leads to the less toxic metabolite HFB1 (<xref rid="B34" ref-type="bibr">34</xref>). We have constructed two different <italic toggle="yes">fumD</italic> expression vectors, with and without the N-terminal secretion signal. While complete <italic toggle="yes">fumD</italic> expression also leads to a low increase in resistance phenotype, the strain lacking the signal peptide (fumD_noL) exhibits high-level FB1 resistance (see <xref rid="F4" ref-type="fig">Fig. 4</xref>). Previously, another detoxification gene from <italic toggle="yes">Aspergillus</italic>, encoding a flavine-dependent amine oxidase, had been described (<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B36" ref-type="bibr">36</xref>). This enzyme converts the amino group of fumonisins into a keto group. We have custom-synthesized the amine oxidase gene with an identical sequence as previously reported (<xref rid="B35" ref-type="bibr">35</xref>) and cloned it behind the <italic toggle="yes">TEF1</italic> promoter. The expression of this gene (without the 6xHis epitope tag in <xref rid="F4" ref-type="fig">Fig. 4</xref>) also led to increased fumonisin B<sub>1</sub> resistance, although at a lower level than YTKT33 expressing <italic toggle="yes">fumD_noL</italic>. In summary, these results show that the engineered yeast strain is a useful tool to validate candidate genes.</p><p>The strain YTKT33 was also used in other applications, for instance, in the classical agar diffusion assay. When seeded into the top agar, application of a crude fungal extract containing FB1 applied to the plate (on a paper disc) produced a clear inhibition zone. As shown in <xref rid="F5" ref-type="fig">Fig. 5</xref>, application of a detoxification enzyme (the commercial product FUM<italic toggle="yes">zyme</italic>) (<xref rid="B37" ref-type="bibr">37</xref>) next to the toxin-containing disc resulted in a diminished and deformed halo as the enzyme diffused into the inhibition zone and inactivated the toxin.</p><fig position="float" fig-type="figure" id="F5"><label>FIG 5</label><caption><p>One hundred microliters of YTKT33 (OD<sub>600</sub> = 0.3) was embedded in SC top agar after equilibration at 48&#x000b0;C and left at room temperature to solidify on SC media (bottom agar). Five microliters of crude FB1 (3,180 mg/L) was added to paper discs (left), while water or FUM<italic toggle="yes">zyme</italic> was added on the right.</p></caption><graphic xlink:href="aem.01211-23.f005" position="float"/></fig></sec></sec><sec sec-type="discussion" id="s3"><title>DISCUSSION</title><p>Wild-type yeast is highly resistant to fumonisins, but we were successfully able to engineer a susceptible strain, YTKT33, by deleting several genes. Fumonisins are highly charged and water-soluble molecules (two tricarballylic acid side groups and a basic amine residue). An interesting, still unsolved question is how fumonisin enters the cell, as it is too polar to pass directly through lipid membranes. Obviously, yeast utilizes ABC transporters to reduce the concentration at the target through active afflux. We combined the described <italic toggle="yes">yor1</italic> mutation with a disruption of <italic toggle="yes">SNQ2</italic> (implicated in resistance to a broad range of mostly cationic compounds). In addition, we inactivated the ABC transporter encoded by <italic toggle="yes">PDR12</italic>, which is required for resistance to various weak acids. We settled for the triple mutant, yet these alterations may also sensitize the strain for other toxins or potentially so-far undescribed fumonisin synergists that might be present in crude extracts.</p><p>Fumonisin FB1 accounted for about 75% of the total B-type fumonisins in the crude extract. The additionally present FB2, FB3, and FB4 cannot fully explain the observed higher toxicity of the crude extract. In principle, other toxins or yet unknown low-toxicity substances acting as synergists of fumonisin might explain the higher toxicity of the crude extract. This effect limits the utility of semi-quantitative determination using the indicator strain in a bioassay. Since the inhibitory activity of the crude extract could be abolished by preincubation with FUM<italic toggle="yes">zyme</italic> (data not shown), the increased IC<sub>50</sub> in the crude extract compared to pure fumonisin is likely due to substances that do not confer toxicity on their own but rather act as synergists of fumonisin.</p><p>Based on previous studies using mammalian cells, there does not appear to be any evidence for a synergism between fumonisin B<sub>1</sub> and frequently co-produced <italic toggle="yes">Fusarium</italic> toxins, e.g., between the cyclic depsipeptides enniatins or beauvericin (<xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B39" ref-type="bibr">39</xref>). Potentially, moniliformin (<xref rid="B40" ref-type="bibr">40</xref>) or fusaproliferin might also be involved, which should be investigated in future work.</p><p>Medium composition and growth conditions have a strong influence on fumonisin toxicity. The binding of fumonisins, acting as competitive inhibitors of ceramide synthase, could be outcompeted by the concentration of the natural substrates of the enzyme that may be abundant, especially in rich media containing yeast extract. Particularly important in rich mediums was the targeting of the recycling pathway. As of yet, little is known about the degradation of complex sphingolipids and their reintegration into the biosynthesis pathway. Yeast produces inositol phosphosphingolipids, which can be hydrolyzed by the <italic toggle="yes">ISC1</italic> gene product (inositol phosphosphingolipid phospholipase C) back to phytoceramide and dihydroceramide, the products of ceramide synthase. This gene might be a candidate for an additional knockout, aiming to further decrease fumonisin resistance on YPD medium.</p><p>Yeast can be screened at high density on microtiter plates, where oxygen supply is low compared to growth on an agar surface. However, the slower (fermentative) growth under oxygen limitation seems to increase FB1 resistance. The concentration to inhibit growth was about one order of magnitude higher in SC liquid medium than in SC-URA agar plates.</p><p>The previously described fumonisin detoxification genes and a gene encoding an insensitive ceramide synthase all conferred FB1 resistance when expressed in YTKT33, validating the utility of the developed strain. The observed resistance level cannot be taken as direct evidence that one enzyme detoxifies better than the other. In a study where <italic toggle="yes">Lemna minor</italic> (duckweed) was exposed to HFB1 and deaminated FB1 (FPy1), the latter exhibited less toxicity than HFB1 (<xref rid="B21" ref-type="bibr">21</xref>). However, the final resistance level is not only caused by the reduced toxicity of the product but is also dependent on the catalytic properties and the expression level of the enzyme, which we have not determined in this study. Nevertheless, it is clear from our results that cytosolic <italic toggle="yes">Sphingopyxis fumD</italic> lacking the bacterial secretion signal can counteract a high level of FB1 entering the cell. It has been reported that hydrolyzed FB1 can be acylated and used as a substrate by ceramide synthases present in rat liver microsomes, forming toxic compounds (<xref rid="B41" ref-type="bibr">41</xref>). Under our experimental settings, even if N-acylation of HFB1 took place, it was insufficient to show toxicity. Hydrolysis of FB1 was also clearly shown to be a useful detoxification strategy in piglets through reduction of intestinal inflammation (<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B42" ref-type="bibr">42</xref>).</p><p>Strain YTKT33 can be employed in the classical agar diffusion assay. Compounds that inhibit fumonisin biosynthesis at concentrations that are not inhibitory for growth have been described, e.g., pyrrocidine (<xref rid="B43" ref-type="bibr">43</xref>). The developed strain could be useful in screens for such substances or to study the mode of action of natural products or plant extracts that seemingly counteract fumonisin toxicity in ill-understood ways, e.g., reference (<xref rid="B44" ref-type="bibr">44</xref>). We have shown that by placing the commercially available detoxification enzyme FUM<italic toggle="yes">zyme</italic> next to the toxin, the deformed halo reveals the detoxification ability of the enzyme. In a more simple setup, preincubating amounts of FB1 with a detoxication agent and observing a diminished inhibition zone would be a possible embodiment of the utilization of the developed strain. Overall, the generated strain is clearly an improvement over previously reported indicator organisms (brine shrimp, hydra, duckweed), with the advantage that it can be used for heterologous expression of foreign genes and for high-throughput screening. It should be useful to identify currently unknown detoxification genes. For instance, it is unclear which gene encodes the fungal acetyltransferase converting FB1 to non-toxic acetylated fumonisin A<sub>1</sub>. Furthermore, there is a lack of knowledge about whether plant enzymes are involved in the production of hidden and bound fumonisins (<xref rid="B45" ref-type="bibr">45</xref>). The yeast indicator strain could be useful to rapidly test mutants of detoxification genes generated by site-directed mutagenesis or to select variants with superior kinetic properties from randomly mutagenized plasmids based on their ability to confer higher levels of resistance than the starting material. This can be achieved through high-throughput screening of the candidate genes using YTKT33. Potentially, novel genes could also be identified by expressing cDNA libraries and selecting resistance-conferring clones, similar to the approach leading to the identification of a deoxynivalenol-inactivating gene (<xref rid="B46" ref-type="bibr">46</xref>).</p></sec><sec sec-type="materials|methods" id="s4"><title>MATERIALS AND METHODS</title><sec id="s4-1"><title>Inactivation of ABC transporters in yeast</title><p>All yeast strains constructed in this work are derived from the yeast laboratory strains YPH500 (Mat&#x003b1;, <italic toggle="yes">ade2-101ochre, his3</italic>&#x00394;<italic toggle="yes">200, leu2</italic>&#x00394;<italic toggle="yes">1, lys2-801amber, trp1</italic>&#x00394;<italic toggle="yes">1, ura3-52</italic>) and YPH499 (<xref rid="B47" ref-type="bibr">47</xref>). For yeast gene nomenclature and composition of synthetic complete medium, see reference (<xref rid="B48" ref-type="bibr">48</xref>). Strains were routinely grown on YPD (1% yeast extract, 2% peptone, 2% dextrose, 2% agarose) and YPG (1% yeast extract, 2% peptone, 3% glycerol, 2% agarose) to identify respiratory competent cells. Information on yeast genes can be found in the Saccharomyces Genome Database [<ext-link xlink:href="https://www.yeastgenome.org/" ext-link-type="uri">https://www.yeastgenome.org/</ext-link>, see reference (<xref rid="B49" ref-type="bibr">49</xref>)]. The strains and their construction are listed in <xref rid="T1" ref-type="table">Table 1</xref>. Single, double, and triple mutants with inactivated ABC transporters Snq2p, Pdr12p, and Yor1p were generated. <italic toggle="yes">YOR1</italic> was disrupted using the pDK30 plasmid kindly provided by Prof. Scott Moye-Rowley (University of Iowa). A restriction digest with BamHI + SacII released a 6.8 kb <italic toggle="yes">yor1::hisG-URA3-hisG</italic> fragment used for transformation (<xref rid="B50" ref-type="bibr">50</xref>). This disruption cassette was also used to transform strains YYM5 (<italic toggle="yes">snq2</italic>) and YRU75 (<italic toggle="yes">pdr12</italic>), as well as the <italic toggle="yes">snq2 pdr12</italic> strain YRE108 (<xref rid="B51" ref-type="bibr">51</xref>), which were kindly provided by Prof. Karl Kuchler (Medical University Vienna). Selection on 5-fluoroorotic acid was used for the removal of the <italic toggle="yes">URA3</italic> marker. <italic toggle="yes">YOR1</italic> disruption was confirmed via PCR screening using internal primers yor1ver_fw and yor1ver_rv, as well as through spotting on YPGE (1% yeast extract, 1% peptone, 3% glycerol, 2% agarose, 3% ethanol) plates containing 0.1 to 0.3 &#x000b5;g/mL oligomycin. Subsequent gene disruptions in the generated triple mutant strain YRU74 were performed using the Cre/<italic toggle="yes">loxP</italic> vector system (<xref rid="B52" ref-type="bibr">52</xref>). Plasmid pOS4a (galactose-inducible <italic toggle="yes">GAL1</italic> promoter-driven Cre recombinase and <italic toggle="yes">ADE2</italic> as selection markers) (<xref rid="B53" ref-type="bibr">53</xref>) was used to excise the <italic toggle="yes">loxP</italic>-flanked markers. Flanking and internal primers were used to screen yeast transformants (for primer sequences, see <xref rid="T2" ref-type="table">Table 2</xref>).</p><table-wrap position="float" id="T2"><label>TABLE 2</label><caption><p>Sequences of primers used in this study<xref rid="T2_FN1" ref-type="table-fn"><sup><italic toggle="yes">a</italic></sup></xref></p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/></colgroup><thead><tr><th align="left" valign="bottom" colspan="1" rowspan="1">Primer name</th><th align="left" valign="bottom" colspan="1" rowspan="1">Sequence (5&#x02032;&#x02013;3&#x02032;)</th></tr></thead><tbody><tr><td align="left" valign="bottom" colspan="1" rowspan="1">yor1ver_fw</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<named-content content-type="sequence">GGTTACGCTATTGGTGCATG</named-content>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">yor1ver_rv</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<named-content content-type="sequence">GCAAGGAAAGTGACCAATG</named-content>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">dcka2-FW</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<named-content content-type="sequence">ATGCCATTACCTCCGTCAACATTGAACCAGAAATCTAATAGAGTC<underline>TCGTACGCTGCAGGTCGAC</underline></named-content>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">dcka2-RV</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<named-content content-type="sequence">TTATTCAAACTTCGTTTTGAAAAACTTATGATCCATAGCCTCCTT<underline>CGCATAGGCCACTAGTGGATCT</underline></named-content>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">cka2_scr-FW</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<named-content content-type="sequence">CAAAGTTGGATATCCCTAATGACC</named-content>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">cka2_scr-RV</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<named-content content-type="sequence">TTACTCAAAAGGTAAATGGCTCTCT</named-content>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">dlcb3-FW</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<named-content content-type="sequence">ATGGTAGATGGACTGAATACCTCGAACATTAGGAAAAGAGCCAGG<underline>TCGTACGCTGCAGGTCGAC</underline></named-content>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">dlcb3-RV</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<named-content content-type="sequence">TTATGCTATATTTAAGAGGGAAAATAGGACGGGGCTGCACATTAC<underline>CGCATAGGCCACTAGTGGATCT</underline></named-content>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">lcb3_scr-FW</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<named-content content-type="sequence">AAGCCTACGTTTTGGACTCTCA</named-content>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">lcb3_scr-RV</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<named-content content-type="sequence">CATGGCCAGCACTATTTTCA</named-content>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">pUG72-REV</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<named-content content-type="sequence">GCGTTTACCGTATCGCAGAATGG</named-content>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">pUG72-FWD</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<named-content content-type="sequence">ATGGCCCAATCACAACCACATCTTAG</named-content>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">pUG73-REV</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<named-content content-type="sequence">ATGCTATCGCCAAGGCTGTCAAGG</named-content>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">pUG73-FWD</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<named-content content-type="sequence">GACACCTTCATCACCTAATTTCTCTTCAAC</named-content>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">VPS51_KO_ pUG_767_fw</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<named-content content-type="sequence">GCGTATTTGCGGTGAGACGGAATCTGACGAGGATATTAAGTACAG</named-content>
<underline>cagctgaagcttcgtacgc</underline>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">VPS51_KO_ pUG_767_rv</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<named-content content-type="sequence">TCTCGAAGGAAGTGTTCGGTGAAAGCCACGATATGCCGCTGGAAA</named-content>
<underline>gcataggccactagtggatctg</underline>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">KlLEU2 rev</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<named-content content-type="sequence">GTTAGAAATGTCTTGGATGCAGGTG</named-content>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">KlLEU2fwd</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<named-content content-type="sequence">CAGCAATGGCATTCAAGACCTTA</named-content>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">VPS51_KO_ upstream_ outside</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<named-content content-type="sequence">ATAGGTGAGGCTCTGCATAG</named-content>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">VPS51_KO_ downstream_ outside</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<named-content content-type="sequence">CGAAGGAAGTGTTCGGTGAAAGC</named-content>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">SmFumD_fw_ Leader</td><td align="left" valign="bottom" colspan="1" rowspan="1">tcccaacgaccgaaaacctgtattttcagggatcc<underline>ATGAAAGAACACCAGTGTAG</underline></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">SmFumD_fw_ noLeader_MAQ</td><td align="left" valign="bottom" colspan="1" rowspan="1">tcccaacgaccgaaaacctgtattttcagggatcc<underline>ATGgctcaaactgacgacccaaa</underline></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">SmFumD_rv</td><td align="left" valign="bottom" colspan="1" rowspan="1">gtcttcaggagcgagttctggctggcttgcacgtg<underline>TTACTTGGATGGTTGACAAG</underline></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">CYC1-RV</td><td align="left" valign="bottom" colspan="1" rowspan="1">ggcgtgaatgtaagcgtgac</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">pVT-U_R4</td><td align="left" valign="bottom" colspan="1" rowspan="1">
<named-content content-type="sequence">GTGGCGAGAAAGGAAGGGAAGA</named-content>
</td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">noHis_Seq_fw</td><td align="left" valign="bottom" colspan="1" rowspan="1">caaaccggatcggactactagc</td></tr></tbody></table><table-wrap-foot><fn id="T2_FN1"><label>
<sup>
<italic toggle="yes">a</italic>
</sup>
</label><p>The underlined part of the sequences is complementary to the beginning or end of the resistance cassette amplified from different plasmids, while the non-underlined part is complementary to the 5&#x02032; or 3&#x02032; end of the gene to be knocked out.</p></fn></table-wrap-foot></table-wrap><p>Single deletions of candidate genes <italic toggle="yes">CKA2</italic> and <italic toggle="yes">LCB3</italic> were generated using plasmid pUG72 as a template to amplify the <italic toggle="yes">loxP-KlURA3-loxP</italic> cassette. Double mutants were obtained by using pUG73 as a template to generate a <italic toggle="yes">loxP-KlLEU2-loxP</italic> cassette. The resulting strain, YRU94 (<italic toggle="yes">snq2</italic>&#x00394;<italic toggle="yes">::hisG pdr12</italic>&#x00394;<italic toggle="yes">::hisG yor1</italic>&#x00394;<italic toggle="yes">::hisG cka2</italic>&#x00394;<italic toggle="yes">::loxP-URA3-loxP, lcb3</italic>&#x00394;<italic toggle="yes">::loxP-LEU2-loxP</italic>), was used for further work. Marker loss was achieved via galactose induction after transformation with pOS4a. Subsequently, a red <italic toggle="yes">ade2</italic> mutant was picked from a YPD plate, indicating the loss of pOS4a in YRU94ML.</p><p>To inactivate <italic toggle="yes">VPS51</italic> in YRU94ML, primers VPS51_KO_pUG_767_fw and VPS51_KO_pUG_767_rv, providing the sequence overhangs for homologous recombination, were used to amplify a <italic toggle="yes">loxP&#x02212; Kluyveromyces lactis LEU2-loxP</italic> construct from pUG73. The correct insertion of the marker (<italic toggle="yes">vps51&#x00394;::loxPKlLEU2-loxP</italic>) in the transformants was confirmed via colony PCR using oligonucleotides flanking the disruption cassette (VPS51_KO_upstream_outside and VPS51_KO_downstream_outside) and primers contained within the <italic toggle="yes">KlLEU2</italic> gene (KlLEU2fwd and KlLEU2 rev), leading to strain YTKT1. Plasmid pBS49 (<italic toggle="yes">GAL1-Cre URA3</italic>) (<xref rid="B54" ref-type="bibr">54</xref>) was used for marker removal. The resulting strain after plasmid loss was designated YTKT33.</p></sec><sec id="s4-2"><title>Treatment with crude or purified fumonisins</title><p>The crude fumonisin extract used during the construction of strains was produced as follows: autoclaved maize media (10 g cracked maize, 1.9 g saccharose, 0.125 g casein hydrolysate, and 5 mL of water) in a 220 mL CultureJar G9 Glass Plant Tissue Culture Vessel (PhytoTech Labs) with Magenta B-Cap vented lids (Bioworld 309300051) were inoculated with conidia of various <italic toggle="yes">Fusarium verticillioides</italic> and <italic toggle="yes">F. proliferatum</italic> strains from our collections and incubated without shaking in the dark at 25&#x000b0;C for 29 days. After the addition of 25 mL of water, the cultures were homogenized, 25 mL of methanol was added, and extraction was performed by shaking for 30 minutes at 140 rpm at room temperature. Then, 1 mL aliquots were cleared by centrifugation (14,680 &#x000d7; <italic toggle="yes">g</italic> for 10 minutes at room temperature). Samples were diluted 1:400 with methanol/water (1:1) for analysis using high pressure liquid chromatography (HPLC). The remaining homogenates were frozen at &#x02212;80&#x000b0;C until workup.</p><p>All homogenates containing &#x02265;250 mg/L of FB1 were thawed, pooled, and centrifuged. Methanol (and partly water) was evaporated using a rotavapor at 35&#x000b0;C until precipitation occurred in the flask. The contents of the flask were centrifuged, and the precipitate was discarded. The fumonisin concentration of the remaining 160 mL of the red-brown, slightly viscous aqueous raw extract was determined, as described below, to be 5.3 g FB1/L. The extract was then slightly diluted and filter sterilized, and the working stock used in experiments was determined to contain 3.18 g/L FB1.</p><p>For the determination of fumonisins, an Agilent 1100 series HPLC was coupled to a Sciex 3500 triple quadrupole mass spectrometer. Separation was achieved on a Phenomenex Gemini C18 column (150&#x000d7; 4.6 mm, 5 &#x000b5;m particle size) at 30&#x000b0;C. Mobile phase A consisted of methanol/water/acetic acid (40/59.9/0.1, vol/vol/vol), while mobile phase B consisted of 0.1% acetic acid in methanol. The initial gradient (0% B) was maintained for 0.5 min before 73% B was reached at 5.9 min. The column was washed with 100% B from 6.0 to 9.9 min before re-equilibration with 0% B from 10.0 to 13.0 min. Then, 1 &#x000b5;L of samples (diluted with 50% aqueous methanol if needed) was injected into a flow of 800 &#x000b5;L/min. Ionization was achieved using a TurboV electrospray source in positive ion mode, applying 4,000 V of ionspray voltage at 550&#x000b0;C, curtain gas of 35 psi, and gas 1 and gas 2 settings of 50 psi each. Selected ion monitoring was employed with 20 ms dwell times for each transition, followed by 5 ms pause times. The following transitions were used [analyte: Q1 mass (Da) &#x0003e;Q3 mass (Da), declustering potential (V), collision energy (eV)]: FB1: 722.3 &#x0003e; 334.2 Da (91 V, 57 eV); FB1 qual: 722.3 &#x0003e; 352.2 Da (91 V, 50 eV); FB2/FB3: 706.3 &#x0003e; 318.3 Da (91 V, 55 eV); FB2/FB3 qual: 706.3 &#x0003e; 336.1 Da (91 V, 50 eV).</p><p>Solid FB1 was either provided by Dr. G. Jaunecker (Romer Labs, Tulln, Austria) or obtained from Fermentek (Jerusalem, Israel). For the comparison of the responses to different B-type fumonisins (<xref rid="F3" ref-type="fig">Fig. 3</xref>), 1 mg of each of FB1, FB2, FB3 (&#x0003e;99%), and FB4 (&#x0003e;98%) was purchased from Fumizol Ltd. (Szeged, Hungary).</p></sec><sec id="s4-3"><title>Growth assays on solid and liquid media</title><p>Both complex (YPD) and SC (synthetic complete) media (<xref rid="B47" ref-type="bibr">47</xref>) supplemented with FB1 were used to conduct growth inhibition tests. For plate assays, liquid overnight cultures were diluted back to an OD<sub>600 nm</sub> of 0.1. After reaching again about 0.3, they were diluted to an OD<sub>600 nm</sub> of 0.1, 0.01, and 0.001, and 3 &#x000b5;L of these suspensions was spotted on the agar plates. Photographs were taken after incubation at 30&#x000b0;C for 5 days. For comparing the sensitivity to FB1 of different strains in liquid media, CELLSTAROneWell flat bottom plates (Greiner Bio-One GmbH, Kremsm&#x000fc;nster, Austria) were placed in a Biotek Synergy H1 Hybrid microplate reader. Plates were incubated at 30&#x000b0;C for 24 h, and OD<sub>600 nm</sub> was measured every hour using a fully automated set-up. A 0.6<sup>N</sup> dilution series of the toxin was prepared manually by adding 120 &#x000b5;L of the previous toxin solution (200 &#x000b5;L in well 1) to 80 &#x000b5;L of prepared toxin-free media (in wells 2) and repeating this step in the following wells (wells 3&#x02013;11) step by step. Then, 80 &#x000b5;L of inoculum was added to each well (1:1 dilution), leading to 11 different concentrations of FB1 and a no-toxin control (well 12). The initial OD<sub>600</sub> of the strains was ~0.05 when diluted 1:1 with the FB1-YPD/SC mixture inside the well plate. Three replicates were used for each strain, and the growth after 24 h was analyzed by calculating the average of the OD<sub>600</sub> of these replicates along with the standard deviation. The value of a blank (medium without yeast) was subtracted. In order to determine the response of the YTKT33 strain to different B-type fumonisins again, a dilution series of 0.6<sup>N</sup> starting at a concentration of 500 &#x000b5;M was prepared in a microtiter plate and SC medium with 250 &#x000b5;M set as the highest one and wells containing only the yeast strain serving as a control. Four replicates were used, and the mean was calculated based on the OD values measured after 24 h, along with the standard deviation.</p></sec><sec id="s4-4"><title>Expression of candidate genes</title><p>Plasmid pYes2-P<sub>TEF1</sub> was used to express different candidate genes expected to confer resistance against FB1. It contains <italic toggle="yes">URA3</italic> as a selection marker, the <italic toggle="yes">TEF1</italic> promoter, and a N-terminal 6xHis-tag (<xref rid="B33" ref-type="bibr">33</xref>). The empty vector, as well as one containing the <italic toggle="yes">Fusarium verticillioides</italic> self-resistance gene (<xref rid="B33" ref-type="bibr">33</xref>), <italic toggle="yes">FUM18,</italic> as a positive control, were kindly provided by Dr. Vito Valiante (Leibniz Institute for Natural Product Research and Infection Biology, Hans Kn&#x000f6;ll Institute, Jena, Germany). The reading frames of other genes of interest were PCR-amplified using a polymerase with proof-reading activity (Phusion High-Fidelity DNA Polymerase, Thermo Fischer Scientific, Vienna, Austria) and about 50-bp-long primers with 35-bp homology to the plasmid and the gene at both the 5&#x02032; and 3&#x02032; ends. The candidate genes were recombined behind the <italic toggle="yes">TEF1</italic> promoter, and the resulting plasmids were recovered from yeast and transformed into <italic toggle="yes">Escherichia coli</italic> by electroporation. For sequence confirmation, primers pVT-U_R4 (see <xref rid="T2" ref-type="table">Table 2</xref>) and CYC1-RV were used.</p><p>The original <italic toggle="yes">Sphingopyxis sp.</italic> MTA144 <italic toggle="yes">fumD</italic> esterase gene recoded for <italic toggle="yes">Pichia</italic> expression (<xref rid="B34" ref-type="bibr">34</xref>) was used as a template for PCR amplification. For generating the construct with the natural bacterial secretion signal, primers SmFumD_rv and SmFumD_fw_Leader were combined. In order to generate the <italic toggle="yes">fumD</italic> construct without a leader, primers SmFumD_rv and SmFumD_fw_noLeader_MAQ were used. The respective PCR products were co-transformed with the BamHI + Eco721 cut vectors for <italic toggle="yes">in vivo</italic> recombination. The <italic toggle="yes">Aspergillus</italic> amine oxidase gene as described (<xref rid="B35" ref-type="bibr">35</xref>) was ordered from BioCat (Heidelberg, Germany), flanked by a sequence containing BamHI and Eco721 for cloning into vector pYes2-P<sub>TEF1</sub>, yielding pTAK37. Modifications were added to this plasmid later on to test for potential negative effects of the 6xHis-tag. Therefore, pTAK37 was cut with BamHI and PvuII (removing the 6xHis-tag) and blunt ends religated after Klenow-fill in. This vector, pTAK38, was used to clone other detoxification genes and transformed into YTKT33 for spotting.</p></sec><sec id="s4-5"><title>Agar diffusion test</title><p>Then, 6 mL of SC top agar equilibrated at 45&#x000b0;C was combined with 100 &#x000b5;L of YTKT33 (OD<sub>600</sub> = 0.3) and poured into 60 mm-diameter petri dishes containing SC bottom agar. Sterile antibiotic discs containing either FB1 (5 &#x000b5;L of &#x0201c;crude FB1&#x0201d; containing 3.18 mg/L FB1), water (control), or FUM<italic toggle="yes">zyme</italic> from Biomin (5 &#x000b5;L of 50 mg/mL) were placed on the solidified dry surface.</p></sec></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>The authors thank Marco Reiter for help in generating the crude extract and Dr. Guenther Jaunecker (Romer Labs) for a generous gift of partially purified FB1. We also thank Profs. Karl Kuchler (University of Vienna) and Prof. Scott Moye-Rowley (University of Iowa) for yeast strains and plasmids, and Dr. Christoph Sch&#x000fc;ller and Dipl. Ing. Christian Puhr (BOKU Core Facility Bioactive Molecules) for help with the use of the microtiter plate reader.</p><p>The initial stages of this work have been funded by Biomin Holding GmbH (part of dsm-firmenich, employing DM), and the final stages by FFoQSI GmbH (Austrian Competence Centre for Feed and Food Quality, Safety &#x00026; Innovation, project C30-P12-W03: Toxin Inactivation). T.K. and K.T. were employed by FFoQSI, and BOKU is a 35% co-owner of FFoQSI. IP rights have been transferred to FFoQSI, which filed a patent application (PCT/EP2023/062973). Additional funding (analytics) was obtained by F.B. from FWF (Austrian Science Fund) project P33011 (Toxicological significance of modified fumonisins).</p><p>Funding acquisition: G.A. and F.B. Conceptualization: R.M. and G.A. Supervision: G.A., G.W. Resources and project administration: D.M. Investigation: R.M., T.K., K.T., N.V., G.W., G.A. and F.B. Writing the original draft: T.K., G.A.</p></ack><sec sec-type="data-availability" id="s5-1"><title>DATA AVAILABILITY</title><p>The sequences of the recoded Sphingopyxis fumD and Aspergillus amine oxidase genes are given in the supplementary material file. fumD accession: <ext-link xlink:href="https://www.uniprot.org/uniprotkb/D2D3B6/entry" ext-link-type="uri">D2D3B6</ext-link>, Aspergillus amine oxidase accesion: <ext-link xlink:href="https://www.uniprot.org/uniprotkb/A2R252/entry" ext-link-type="uri">A2R252</ext-link>. Strain requests (by means of a material transfer agreement) should be directed to FFoQSI (juergen.marchart@ffoqsi.at).</p></sec><sec sec-type="supplementary-material" id="s5-2"><title>SUPPLEMENTAL MATERIAL</title><p specific-use="print-only">The following material is available online at <ext-link xlink:href="https://doi.org/10.1128/aem.01211-23" ext-link-type="uri">https://doi.org/10.1128/aem.01211-23</ext-link>.</p><supplementary-material id="SuF1" position="float" content-type="local-data"><object-id pub-id-type="doi">10.1128/aem.01211-23.SuF1</object-id><label>Recoded genes</label><caption><title>aem.01211-23-s0001.docx</title><p>Gene sequences.</p></caption><media xlink:href="aem.01211-23-s0001.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><p specific-use="online-only">ASM does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article. The authors have granted ASM a non-exclusive, world-wide license to publish the Supplemental Material files. Please contact the corresponding author directly for reuse. </p></sec><ref-list><title>REFERENCES</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Munkvold</surname>
<given-names>GP</given-names></string-name>, <string-name><surname>Proctor</surname>
<given-names>RH</given-names></string-name>, <string-name><surname>Moretti</surname>
<given-names>A</given-names></string-name></person-group>. <year>2021</year>. <article-title>Mycotoxin production in Fusarium according to contemporary species concepts</article-title>. <source>Annu Rev Phytopathol</source>
<volume>59</volume>:<fpage>373</fpage>&#x02013;<lpage>402</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev-phyto-020620-102825</pub-id><pub-id pub-id-type="pmid">34077240</pub-id>
</mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Yli-Mattila</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Sundheim</surname>
<given-names>L</given-names></string-name></person-group>. <year>2022</year>. <article-title>Fumonisins in African countries</article-title>. <source>Toxins (Basel)</source>
<volume>14</volume>:<elocation-id>419</elocation-id>. doi:<pub-id pub-id-type="doi">10.3390/toxins14060419</pub-id><pub-id pub-id-type="pmid">35737080</pub-id>
</mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Castell&#x000e1;</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Bragulat</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Caba&#x000f1;es</surname>
<given-names>FJ</given-names></string-name></person-group>. <year>1999</year>. <article-title>Fumonisin production by Fusarium species isolated from cereals and feeds in Spain</article-title>. <source>J Food Prot</source>
<volume>62</volume>:<fpage>811</fpage>&#x02013;<lpage>813</lpage>. doi:<pub-id pub-id-type="doi">10.4315/0362-028x-62.7.811</pub-id><pub-id pub-id-type="pmid">10419279</pub-id>
</mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Cendoya</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Chiotta</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Zachetti</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Chulze</surname>
<given-names>SN</given-names></string-name>, <string-name><surname>Ramirez</surname>
<given-names>ML</given-names></string-name></person-group>. <year>2018</year>. <article-title>Fumonisins and fumonisin-producing Fusarium occurrence in wheat and wheat by products: a review</article-title>. <source>J Cereal Sci</source>
<volume>80</volume>:<fpage>158</fpage>&#x02013;<lpage>166</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jcs.2018.02.010</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Farhadi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Fakhri</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Kachuei</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Vasseghian</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Huseyn</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Mousavi Khaneghah</surname>
<given-names>A</given-names></string-name></person-group>. <year>2021</year>. <article-title>Prevalence and concentration of fumonisins in cereal-based foods: a global systematic review and meta-analysis study</article-title>. <source>Environ Sci Pollut Res Int</source>
<volume>28</volume>:<fpage>20998</fpage>&#x02013;<lpage>21008</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11356-021-12671-w</pub-id><pub-id pub-id-type="pmid">33694116</pub-id>
</mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Abbas</surname>
<given-names>HK</given-names></string-name>, <string-name><surname>Cartwright</surname>
<given-names>RD</given-names></string-name>, <string-name><surname>Shier</surname>
<given-names>WT</given-names></string-name>, <string-name><surname>Abouzied</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Bird</surname>
<given-names>CB</given-names></string-name>, <string-name><surname>Rice</surname>
<given-names>LG</given-names></string-name>, <string-name><surname>Ross</surname>
<given-names>PF</given-names></string-name>, <string-name><surname>Sciumbato</surname>
<given-names>GL</given-names></string-name>, <string-name><surname>Meredith</surname>
<given-names>FI</given-names></string-name></person-group>. <year>1998</year>. <article-title>Natural occurrence of fumonisins in rice with Fusarium sheath rot disease</article-title>. <source>Plant Dis</source>
<volume>82</volume>:<fpage>22</fpage>&#x02013;<lpage>25</lpage>. doi:<pub-id pub-id-type="doi">10.1094/PDIS.1998.82.1.22</pub-id><pub-id pub-id-type="pmid">30857062</pub-id>
</mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Sun</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Gao</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Hou</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>S</given-names></string-name></person-group>. <year>2019</year>. <article-title>Effects of disruption of five FUM genes on fumonisin biosynthesis and pathogenicity in Fusarium proliferatum</article-title>. <source>Toxins</source>
<volume>11</volume>:<fpage>327</fpage>. doi:<pub-id pub-id-type="doi">10.3390/toxins11060327</pub-id><pub-id pub-id-type="pmid">31181598</pub-id>
</mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Glenn</surname>
<given-names>AE</given-names></string-name>, <string-name><surname>Zitomer</surname>
<given-names>NC</given-names></string-name>, <string-name><surname>Zimeri</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Williams</surname>
<given-names>LD</given-names></string-name>, <string-name><surname>Riley</surname>
<given-names>RT</given-names></string-name>, <string-name><surname>Proctor</surname>
<given-names>RH</given-names></string-name></person-group>. <year>2008</year>. <article-title>Transformation-mediated complementation of a FUM gene cluster deletion in Fusarium verticillioides restores both fumonisin production and pathogenicity on maize seedlings</article-title>. <source>Mol Plant Microbe Interact</source>
<volume>21</volume>:<fpage>87</fpage>&#x02013;<lpage>97</lpage>. doi:<pub-id pub-id-type="doi">10.1094/MPMI-21-1-0087</pub-id><pub-id pub-id-type="pmid">18052886</pub-id>
</mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Desjardins</surname>
<given-names>AE</given-names></string-name>, <string-name><surname>Munkvold</surname>
<given-names>GP</given-names></string-name>, <string-name><surname>Plattner</surname>
<given-names>RD</given-names></string-name>, <string-name><surname>Proctor</surname>
<given-names>RH</given-names></string-name></person-group>. <year>2002</year>. <article-title>FUM1--a gene required for fumonisin biosynthesis but not for maize ear rot and ear infection by Gibberella moniliformis in field tests</article-title>. <source>Mol Plant Microbe Interact</source>
<volume>15</volume>:<fpage>1157</fpage>&#x02013;<lpage>1164</lpage>. doi:<pub-id pub-id-type="doi">10.1094/MPMI.2002.15.11.1157</pub-id><pub-id pub-id-type="pmid">12423021</pub-id>
</mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><collab>EFSA Panel on Contaminants in the Food Chain (CONTAM)</collab></person-group>. <year>2014</year>. <article-title>Scientific opinion on the risks for human and animal health related to the presence of modified forms of certain mycotoxins in food and feed</article-title>. <source>EFSA J</source>
<volume>12</volume>:<fpage>3916</fpage>. doi:<pub-id pub-id-type="doi">10.2903/j.efsa.2014.3916</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Chen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Cheng</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Gao</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Guo</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>J</given-names></string-name></person-group>. <year>2020</year>. <article-title>Sphinganine-analog mycotoxins (SAMs): chemical structures, bioactivities, and genetic controls</article-title>. <source>J Fungi (Basel)</source>
<volume>6</volume>:<elocation-id>312</elocation-id>. doi:<pub-id pub-id-type="doi">10.3390/jof6040312</pub-id><pub-id pub-id-type="pmid">33255427</pub-id>
</mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><string-name><surname>Merrill</surname>
<given-names>AH</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Vales</surname>
<given-names>TR</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>ER</given-names></string-name>, <string-name><surname>Schroeder</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Menaldino</surname>
<given-names>DS</given-names></string-name>, <string-name><surname>Alexander</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Crane</surname>
<given-names>HM</given-names></string-name>, <string-name><surname>Xia</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Liotta</surname>
<given-names>DC</given-names></string-name>, <string-name><surname>Meredith</surname>
<given-names>FI</given-names></string-name>, <string-name><surname>Riley</surname>
<given-names>RT</given-names></string-name></person-group>. <year>1996</year>. <part-title>Fumonisin toxicity and sphingolipid biosynthesis</part-title>, <comment>p</comment>
<fpage>297</fpage>&#x02013;<lpage>306</lpage>. In <person-group person-group-type="editor"><string-name><surname>Jackson</surname>
<given-names>LS</given-names></string-name>, <string-name><given-names>JW</given-names>
<surname>DeVries</surname></string-name>, <string-name><given-names>LB</given-names>
<surname>Bullerman</surname></string-name></person-group> (ed), <source>Fumonisins in food</source>. <publisher-name>Springer US</publisher-name>, <publisher-loc>Boston, MA</publisher-loc>.</mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Luttgeharm</surname>
<given-names>KD</given-names></string-name>, <string-name><surname>Cahoon</surname>
<given-names>EB</given-names></string-name>, <string-name><surname>Markham</surname>
<given-names>JE</given-names></string-name></person-group>. <year>2016</year>. <article-title>Substrate specificity, kinetic properties and inhibition by fumonisin B1 of ceramide synthase isoforms from arabidopsis</article-title>. <source>Biochem J</source>
<volume>473</volume>:<fpage>593</fpage>&#x02013;<lpage>603</lpage>. doi:<pub-id pub-id-type="doi">10.1042/BJ20150824</pub-id><pub-id pub-id-type="pmid">26635357</pub-id>
</mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Berkey</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Bendigeri</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Xiao</surname>
<given-names>S</given-names></string-name></person-group>. <year>2012</year>. <article-title>Sphingolipids and plant defense/disease: the &#x0201c;death&#x0201d; connection and beyond</article-title>. <source>Front Plant Sci</source>
<volume>3</volume>:<elocation-id>68</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fpls.2012.00068</pub-id><pub-id pub-id-type="pmid">22639658</pub-id>
</mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Zeng</surname>
<given-names>H-Y</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>C-Y</given-names></string-name>, <string-name><surname>Yao</surname>
<given-names>N</given-names></string-name></person-group>. <year>2020</year>. <article-title>Fumonisin B1: a tool for exploring the multiple functions of sphingolipids in plants</article-title>. <source>Front Plant Sci</source>
<volume>11</volume>:<elocation-id>600458</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fpls.2020.600458</pub-id><pub-id pub-id-type="pmid">33193556</pub-id>
</mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Chen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Wei</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Long</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Kuca</surname>
<given-names>K</given-names></string-name></person-group>. <year>2021</year>. <article-title>Fumonisin B1: mechanisms of toxicity and biological detoxification progress in animals</article-title>. <source>Food Chem Toxicol</source>
<volume>149</volume>:<elocation-id>111977</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.fct.2021.111977</pub-id><pub-id pub-id-type="pmid">33428988</pub-id>
</mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Molina-Pintor</surname>
<given-names>IB</given-names></string-name>, <string-name><surname>Rojas-Garc&#x000ed;a</surname>
<given-names>AE</given-names></string-name>, <string-name><surname>Medina-D&#x000ed;az</surname>
<given-names>IM</given-names></string-name>, <string-name><surname>Barr&#x000f3;n-Vivanco</surname>
<given-names>BS</given-names></string-name>, <string-name><surname>Bernal-Hern&#x000e1;ndez</surname>
<given-names>YY</given-names></string-name>, <string-name><surname>Ortega-Cervantes</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Ramos</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Herrera-Moreno</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Gonz&#x000e1;lez-Arias</surname>
<given-names>CA</given-names></string-name></person-group>. <year>2022</year>. <article-title>An update on genotoxic and epigenetic studies of fumonisin B1</article-title>. <source>World Mycotoxin J</source>
<volume>15</volume>:<fpage>57</fpage>&#x02013;<lpage>72</lpage>. doi:<pub-id pub-id-type="doi">10.3920/WMJ2021.2720</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Gelderblom</surname>
<given-names>WCA</given-names></string-name>, <string-name><surname>Cawood</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Snyman</surname>
<given-names>SD</given-names></string-name>, <string-name><surname>Vleggaar</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Marasas</surname>
<given-names>WFO</given-names></string-name></person-group>. <year>1993</year>. <article-title>Structure-activity relationships of fumonisins in short-term carcinogenesis and cytotoxicity assays</article-title>. <source>Food Chem Toxicol</source>
<volume>31</volume>:<fpage>407</fpage>&#x02013;<lpage>414</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0278-6915(93)90155-R</pub-id><pub-id pub-id-type="pmid">8514212</pub-id>
</mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>McKean</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Billam</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Theodorakis</surname>
<given-names>CW</given-names></string-name>, <string-name><surname>Kendall</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>J-S</given-names></string-name></person-group>. <year>2006</year>. <article-title>Comparative acute and combinative toxicity of aflatoxin B1 and fumonisin B1 in animals and human cells</article-title>. <source>Food Chem Toxicol</source>
<volume>44</volume>:<fpage>868</fpage>&#x02013;<lpage>876</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.fct.2005.11.011</pub-id><pub-id pub-id-type="pmid">16427177</pub-id>
</mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Stone</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Heard</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Asai</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Ausubel</surname>
<given-names>FM</given-names></string-name></person-group>. <year>2000</year>. <article-title>Simulation of fungal-mediated cell death by fumonisin B1 and selection of fumonisin B1&#x02013;resistant (fbr) Arabidopsis mutants</article-title>. <source>Plant Cell</source>
<volume>12</volume>:<fpage>1811</fpage>&#x02013;<lpage>1822</lpage>. doi:<pub-id pub-id-type="doi">10.1105/tpc.12.10.1811</pub-id><pub-id pub-id-type="pmid">11041878</pub-id>
</mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Renaud</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>DesRochers</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Hoogstra</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Garnham</surname>
<given-names>CP</given-names></string-name>, <string-name><surname>Sumarah</surname>
<given-names>MW</given-names></string-name></person-group>. <year>2021</year>. <article-title>Structure activity relationship for fumonisin phytotoxicity</article-title>. <source>Chem Res Toxicol</source>
<volume>34</volume>:<fpage>1604</fpage>&#x02013;<lpage>1611</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acs.chemrestox.1c00057</pub-id><pub-id pub-id-type="pmid">33891387</pub-id>
</mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Lemke</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Ottinger</surname>
<given-names>SE</given-names></string-name>, <string-name><surname>Ake</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Mayura</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Phillips</surname>
<given-names>TD</given-names></string-name></person-group>. <year>2001</year>. <article-title>Deamination of fumonisin B1 and biological assessment of reaction product toxicity</article-title>. <source>Chem Res Toxicol</source>
<volume>14</volume>:<fpage>11</fpage>&#x02013;<lpage>15</lpage>. doi:<pub-id pub-id-type="doi">10.1021/tx000166d</pub-id><pub-id pub-id-type="pmid">11170503</pub-id>
</mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Hlywka</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Beck</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Bullerman</surname>
<given-names>LB</given-names></string-name></person-group>. <year>1997</year>. <article-title>The use of the chicken embryo screening test and brine shrimp (Artemia salina) bioassays to assess the toxicity of fumonisin B1 mycotoxin</article-title>. <source>Food Chem Toxicol</source>
<volume>35</volume>:<fpage>991</fpage>&#x02013;<lpage>999</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0278-6915(97)87268-7</pub-id><pub-id pub-id-type="pmid">9463533</pub-id>
</mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Hartl</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Humpf</surname>
<given-names>HU</given-names></string-name></person-group>. <year>2000</year>. <article-title>Toxicity assessment of fumonisins using the brine shrimp (Artemia salina) bioassay</article-title>. <source>Food Chem Toxicol</source>
<volume>38</volume>:<fpage>1097</fpage>&#x02013;<lpage>1102</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0278-6915(00)00112-5</pub-id><pub-id pub-id-type="pmid">11033198</pub-id>
</mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Grenier</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Bracarense</surname>
<given-names>A-P</given-names></string-name>, <string-name><surname>Schwartz</surname>
<given-names>HE</given-names></string-name>, <string-name><surname>Lucioli</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Cossalter</surname>
<given-names>A-M</given-names></string-name>, <string-name><surname>Moll</surname>
<given-names>W-D</given-names></string-name>, <string-name><surname>Schatzmayr</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Oswald</surname>
<given-names>IP</given-names></string-name></person-group>. <year>2013</year>. <article-title>Biotransformation approaches to alleviate the effects induced by Fusarium mycotoxins in swine</article-title>. <source>J Agric Food Chem</source>
<volume>61</volume>:<fpage>6711</fpage>&#x02013;<lpage>6719</lpage>. doi:<pub-id pub-id-type="doi">10.1021/jf400213q</pub-id><pub-id pub-id-type="pmid">23758213</pub-id>
</mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Duvick</surname>
<given-names>J</given-names></string-name></person-group>. <year>2001</year>. <article-title>Prospects for reducing fumonisin contamination of maize through genetic modification</article-title>. <source>Environ Health Perspect</source>
<volume>109 Suppl 2</volume>:<fpage>337</fpage>&#x02013;<lpage>342</lpage>. doi:<pub-id pub-id-type="doi">10.1289/ehp.01109s2337</pub-id><pub-id pub-id-type="pmid">11359705</pub-id>
</mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Mao</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Bielawska</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Obeid</surname>
<given-names>LM</given-names></string-name></person-group>. <year>2000</year>. <article-title>Cloning of an alkaline ceramidase from Saccharomyces cerevisiae. An enzyme with reverse (CoA-independent) ceramide synthase activity</article-title>. <source>J Biol Chem</source>
<volume>275</volume>:<fpage>6876</fpage>&#x02013;<lpage>6884</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.275.10.6876</pub-id><pub-id pub-id-type="pmid">10702247</pub-id>
</mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Bauer</surname>
<given-names>BE</given-names></string-name>, <string-name><surname>Wolfger</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Kuchler</surname>
<given-names>K</given-names></string-name></person-group>. <year>1999</year>. <article-title>Inventory and function of yeast ABC proteins: about sex, stress, pleiotropic drug and heavy metal resistance</article-title>. <source>Biochim Biophys Acta</source>
<volume>1461</volume>:<fpage>217</fpage>&#x02013;<lpage>236</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0005-2736(99)00160-1</pub-id><pub-id pub-id-type="pmid">10581358</pub-id>
</mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Kobayashi</surname>
<given-names>SD</given-names></string-name>, <string-name><surname>Nagiec</surname>
<given-names>MM</given-names></string-name></person-group>. <year>2003</year>. <article-title>Ceramide/long-chain base phosphate rheostat in Saccharomyces cerevisiae: regulation of ceramide synthesis by Elo3p and Cka2p</article-title>. <source>Eukaryot Cell</source>
<volume>2</volume>:<fpage>284</fpage>&#x02013;<lpage>294</lpage>. doi:<pub-id pub-id-type="doi">10.1128/EC.2.2.284-294.2003</pub-id><pub-id pub-id-type="pmid">12684378</pub-id>
</mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Fr&#x000f6;hlich</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Petit</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Kory</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Christiano</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Hannibal-Bach</surname>
<given-names>H-K</given-names></string-name>, <string-name><surname>Graham</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Ejsing</surname>
<given-names>CS</given-names></string-name>, <string-name><surname>Farese</surname>
<given-names>RV</given-names></string-name>, <string-name><surname>Walther</surname>
<given-names>TC</given-names></string-name></person-group>. <year>2015</year>. <article-title>The GARP complex is required for cellular sphingolipid homeostasis</article-title>. <source>Elife</source>
<volume>4</volume>:<elocation-id>e08712</elocation-id>. doi:<pub-id pub-id-type="doi">10.7554/eLife.08712</pub-id><pub-id pub-id-type="pmid">26357016</pub-id>
</mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Rheeder</surname>
<given-names>JP</given-names></string-name>, <string-name><surname>Marasas</surname>
<given-names>WFO</given-names></string-name>, <string-name><surname>Vismer</surname>
<given-names>HF</given-names></string-name></person-group>. <year>2002</year>. <article-title>Production of fumonisin analogs by Fusarium species</article-title>. <source>Appl Environ Microbiol</source>
<volume>68</volume>:<fpage>2101</fpage>&#x02013;<lpage>2105</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AEM.68.5.2101-2105.2002</pub-id><pub-id pub-id-type="pmid">11976077</pub-id>
</mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Dickson</surname>
<given-names>RC</given-names></string-name>, <string-name><surname>Nagiec</surname>
<given-names>EE</given-names></string-name>, <string-name><surname>Skrzypek</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Tillman</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Wells</surname>
<given-names>GB</given-names></string-name>, <string-name><surname>Lester</surname>
<given-names>RL</given-names></string-name></person-group>. <year>1997</year>. <article-title>Sphingolipids are potential heat stress signals in Saccharomyces</article-title>. <source>J Biol Chem</source>
<volume>272</volume>:<fpage>30196</fpage>&#x02013;<lpage>30200</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.272.48.30196</pub-id><pub-id pub-id-type="pmid">9374502</pub-id>
</mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Janevska</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ferling</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Joji&#x00107;</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Rautschek</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Hoefgen</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Proctor</surname>
<given-names>RH</given-names></string-name>, <string-name><surname>Hillmann</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Valiante</surname>
<given-names>V</given-names></string-name></person-group>. <year>2020</year>. <article-title>Self-protection against the sphingolipid biosynthesis inhibitor fumonisin B<sub>1</sub> is conferred by a FUM cluster-encoded ceramide synthase</article-title>. <source>mBio</source>
<volume>11</volume>:<elocation-id>e00455-20</elocation-id>. doi:<pub-id pub-id-type="doi">10.1128/mBio.00455-20</pub-id><pub-id pub-id-type="pmid">32546615</pub-id>
</mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Heinl</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Hartinger</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Thamhesl</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Vekiru</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Krska</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Schatzmayr</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Moll</surname>
<given-names>W-D</given-names></string-name>, <string-name><surname>Grabherr</surname>
<given-names>R</given-names></string-name></person-group>. <year>2010</year>. <article-title>Degradation of fumonisin B1 by the consecutive action of two bacterial enzymes</article-title>. <source>J Biotechnol</source>
<volume>145</volume>:<fpage>120</fpage>&#x02013;<lpage>129</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jbiotec.2009.11.004</pub-id><pub-id pub-id-type="pmid">19922747</pub-id>
</mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Garnham</surname>
<given-names>CP</given-names></string-name>, <string-name><surname>Butler</surname>
<given-names>SG</given-names></string-name>, <string-name><surname>Telmer</surname>
<given-names>PG</given-names></string-name>, <string-name><surname>Black</surname>
<given-names>FE</given-names></string-name>, <string-name><surname>Renaud</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>Sumarah</surname>
<given-names>MW</given-names></string-name></person-group>. <year>2020</year>. <article-title>Identification and characterization of an Aspergillus niger amine oxidase that detoxifies intact fumonisins</article-title>. <source>J Agric Food Chem</source>
<volume>68</volume>:<fpage>13779</fpage>&#x02013;<lpage>13790</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acs.jafc.0c04504</pub-id><pub-id pub-id-type="pmid">33174732</pub-id>
</mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Telmer</surname>
<given-names>PG</given-names></string-name>, <string-name><surname>Kelman</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Renaud</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>Sumarah</surname>
<given-names>MW</given-names></string-name>, <string-name><surname>Garnham</surname>
<given-names>CP</given-names></string-name></person-group>. <year>2022</year>. <article-title>Application of Aspergillus niger fumonisin amine oxidase (AnFAO) to detoxify fumonisin-contaminated maize</article-title>. <source>Toxins (Basel)</source>
<volume>14</volume>:<elocation-id>544</elocation-id>. doi:<pub-id pub-id-type="doi">10.3390/toxins14080544</pub-id><pub-id pub-id-type="pmid">36006206</pub-id>
</mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Bampidis</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Azimonti</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Bastos</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Christensen</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Dusemund</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Kos Durjava</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kouba</surname>
<given-names>M</given-names></string-name>, <string-name><surname>L&#x000f3;pez-Alonso</surname>
<given-names>M</given-names></string-name>, <string-name><surname>L&#x000f3;pez Puente</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Marcon</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Mayo</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Pechov&#x000e1;</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Petkova</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ramos</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Sanz</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Villa</surname>
<given-names>RE</given-names></string-name>, <string-name><surname>Woutersen</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Brozzi</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Galobart</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Gregoretti</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Innocenti</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Sofianidis</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Vettori</surname>
<given-names>MV</given-names></string-name>, <string-name><surname>L&#x000f3;pez-G&#x000e1;lvez</surname>
<given-names>G</given-names></string-name>, <collab>EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)</collab></person-group>. <year>2020</year>. <article-title>Safety and efficacy of fumonisin esterase from Komagataella phaffii DSM 32159 as a feed additive for all animal species</article-title>. <source>EFSA J</source>
<volume>18</volume>:<elocation-id>e06207</elocation-id>. doi:<pub-id pub-id-type="doi">10.2903/j.efsa.2020.6207</pub-id><pub-id pub-id-type="pmid">32699560</pub-id>
</mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Alassane-Kpembi</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Schatzmayr</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Taranu</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Marin</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Puel</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Oswald</surname>
<given-names>IP</given-names></string-name></person-group>. <year>2017</year>. <article-title>Mycotoxins co-contamination: methodological aspects and biological relevance of combined toxicity studies</article-title>. <source>Crit Rev Food Sci Nutr</source>
<volume>57</volume>:<fpage>3489</fpage>&#x02013;<lpage>3507</lpage>. doi:<pub-id pub-id-type="doi">10.1080/10408398.2016.1140632</pub-id><pub-id pub-id-type="pmid">26918653</pub-id>
</mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>P&#x000e9;rez-Fuentes</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Alvari&#x000f1;o</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Alfonso</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Gonz&#x000e1;lez-Jart&#x000ed;n</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Gegunde</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Vieytes</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Botana</surname>
<given-names>LM</given-names></string-name></person-group>. <year>2021</year>. <article-title>Single and combined effects of regulated and emerging mycotoxins on viability and mitochondrial function of SH-SY5Y cells</article-title>. <source>Food Chem Toxicol</source>
<volume>154</volume>:<elocation-id>112308</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.fct.2021.112308</pub-id><pub-id pub-id-type="pmid">34062223</pub-id>
</mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Sharma</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Asrani</surname>
<given-names>RK</given-names></string-name>, <string-name><surname>Ledoux</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Rottinghaus</surname>
<given-names>GE</given-names></string-name>, <string-name><surname>Gupta</surname>
<given-names>VK</given-names></string-name></person-group>. <year>2012</year>. <article-title>Toxic interaction between fumonisin B1 and moniliformin for cardiac lesions in Japanese quail</article-title>. <source>Avian Dis</source>
<volume>56</volume>:<fpage>545</fpage>&#x02013;<lpage>554</lpage>. doi:<pub-id pub-id-type="doi">10.1637/10036-121111-Reg.1</pub-id><pub-id pub-id-type="pmid">23050472</pub-id>
</mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Seiferlein</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Humpf</surname>
<given-names>H-U</given-names></string-name>, <string-name><surname>Voss</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Sullards</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Allegood</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Merrill</surname>
<given-names>AH</given-names></string-name></person-group>. <year>2007</year>. <article-title>Hydrolyzed fumonisins HFB1 and HFB2 are acylated in vitro and in vivo by ceramide synthase to form cytotoxic N-acyl-metabolites</article-title>. <source>Mol Nutr Food Res</source>
<volume>51</volume>:<fpage>1120</fpage>&#x02013;<lpage>1130</lpage>. doi:<pub-id pub-id-type="doi">10.1002/mnfr.200700118</pub-id><pub-id pub-id-type="pmid">17729221</pub-id>
</mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Gu</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Han</surname>
<given-names>SE</given-names></string-name>, <string-name><surname>Hwang</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Mayer</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Reisinger</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Schatzmayr</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Park</surname>
<given-names>B-C</given-names></string-name>, <string-name><surname>Han</surname>
<given-names>SH</given-names></string-name>, <string-name><surname>Yun</surname>
<given-names>C-H</given-names></string-name></person-group>. <year>2019</year>. <article-title>Hydrolyzed fumonisin B1 induces less inflammatory responses than fumonisin B1 in the co-culture model of porcine intestinal epithelial and immune cells</article-title>. <source>Toxicol Lett</source>
<volume>305</volume>:<fpage>110</fpage>&#x02013;<lpage>116</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.toxlet.2019.01.013</pub-id><pub-id pub-id-type="pmid">30708112</pub-id>
</mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Gao</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Glenn</surname>
<given-names>AE</given-names></string-name>, <string-name><surname>Gu</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Mitchell</surname>
<given-names>TR</given-names></string-name>, <string-name><surname>Satterlee</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Duke</surname>
<given-names>MV</given-names></string-name>, <string-name><surname>Scheffler</surname>
<given-names>BE</given-names></string-name>, <string-name><surname>Gold</surname>
<given-names>SE</given-names></string-name></person-group>. <year>2020</year>. <article-title>Pyrrocidine, a molecular off switch for fumonisin biosynthesis</article-title>. <source>PLoS Pathog</source>
<volume>16</volume>:<elocation-id>e1008595</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1008595</pub-id><pub-id pub-id-type="pmid">32628727</pub-id>
</mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Gao</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Luo</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Zhu</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Peng</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>H</given-names></string-name></person-group>. <year>2023</year>. <article-title>The natural occurrence, toxicity mechanisms and management strategies of fumonisin B1: a review</article-title>. <source>Environ Pollut</source>
<volume>320</volume>:<fpage>121065</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.envpol.2023.121065</pub-id><pub-id pub-id-type="pmid">36639041</pub-id>
</mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Dall&#x02019;Asta</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Mangia</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Berthiller</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Molinelli</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Sulyok</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Schuhmacher</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Krska</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Galaverna</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Dossena</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Marchelli</surname>
<given-names>R</given-names></string-name></person-group>. <year>2009</year>. <article-title>Difficulties in fumonisin determination: the issue of hidden fumonisins</article-title>. <source>Anal Bioanal Chem</source>
<volume>395</volume>:<fpage>1335</fpage>&#x02013;<lpage>1345</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00216-009-2933-3</pub-id><pub-id pub-id-type="pmid">19588126</pub-id>
</mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Poppenberger</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Berthiller</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Lucyshyn</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Sieberer</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Schuhmacher</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Krska</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Kuchler</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Gl&#x000f6;ssl</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Luschnig</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Adam</surname>
<given-names>G</given-names></string-name></person-group>. <year>2003</year>. <article-title>Detoxification of the Fusarium mycotoxin deoxynivalenol by a UDP-glucosyltransferase from Arabidopsis thaliana</article-title>. <source>J Biol Chem</source>
<volume>278</volume>:<fpage>47905</fpage>&#x02013;<lpage>47914</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M307552200</pub-id><pub-id pub-id-type="pmid">12970342</pub-id>
</mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Sikorski</surname>
<given-names>RS</given-names></string-name>, <string-name><surname>Hieter</surname>
<given-names>P</given-names></string-name></person-group>. <year>1989</year>. <article-title>A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae</article-title>. <source>Genetics</source>
<volume>122</volume>:<fpage>19</fpage>&#x02013;<lpage>27</lpage>. doi:<pub-id pub-id-type="doi">10.1093/genetics/122.1.19</pub-id><pub-id pub-id-type="pmid">2659436</pub-id>
</mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Sherman</surname>
<given-names>F</given-names></string-name></person-group>. <year>1991</year>. <article-title>Getting started with yeast</article-title>. <source>Methods Enzymol</source>
<volume>194</volume>:<fpage>3</fpage>&#x02013;<lpage>21</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0076-6879(91)94004-v</pub-id><pub-id pub-id-type="pmid">2005794</pub-id>
</mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Cherry</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Hong</surname>
<given-names>EL</given-names></string-name>, <string-name><surname>Amundsen</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Balakrishnan</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Binkley</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Chan</surname>
<given-names>ET</given-names></string-name>, <string-name><surname>Christie</surname>
<given-names>KR</given-names></string-name>, <string-name><surname>Costanzo</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Dwight</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>Engel</surname>
<given-names>SR</given-names></string-name>, <string-name><surname>Fisk</surname>
<given-names>DG</given-names></string-name>, <string-name><surname>Hirschman</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Hitz</surname>
<given-names>BC</given-names></string-name>, <string-name><surname>Karra</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Krieger</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Miyasato</surname>
<given-names>SR</given-names></string-name>, <string-name><surname>Nash</surname>
<given-names>RS</given-names></string-name>, <string-name><surname>Park</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Skrzypek</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Simison</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Weng</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Wong</surname>
<given-names>ED</given-names></string-name></person-group>. <year>2012</year>. <article-title>Saccharomyces genome database: the genomics resource of budding yeast</article-title>. <source>Nucleic Acids Res</source>
<volume>40</volume>:<fpage>D700</fpage>&#x02013;<lpage>D705</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkr1029</pub-id><pub-id pub-id-type="pmid">22110037</pub-id>
</mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Katzmann</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Hallstrom</surname>
<given-names>TC</given-names></string-name>, <string-name><surname>Voet</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Wysock</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Golin</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Volckaert</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Moye-Rowley</surname>
<given-names>WS</given-names></string-name></person-group>. <year>1995</year>. <article-title>Expression of an ATP-binding cassette transporter-encoding gene (YOR1) is required for oligomycin resistance in Saccharomyces cerevisiae</article-title>. <source>Mol Cell Biol</source>
<volume>15</volume>:<fpage>6875</fpage>&#x02013;<lpage>6883</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.15.12.6875</pub-id><pub-id pub-id-type="pmid">8524254</pub-id>
</mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Emerson</surname>
<given-names>LR</given-names></string-name>, <string-name><surname>Skillman</surname>
<given-names>BC</given-names></string-name>, <string-name><surname>Wolfger</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Kuchler</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Wirth</surname>
<given-names>DF</given-names></string-name></person-group>. <year>2004</year>. <article-title>The sensitivities of yeast strains deficient in PDR ABC transporters, to quinoline-ring antimalarial drugs</article-title>. <source>Ann Trop Med Parasitol</source>
<volume>98</volume>:<fpage>643</fpage>&#x02013;<lpage>649</lpage>. doi:<pub-id pub-id-type="doi">10.1179/000349804225021523</pub-id><pub-id pub-id-type="pmid">15324472</pub-id>
</mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Gueldener</surname>
<given-names>U</given-names></string-name>, <string-name><surname>Heinisch</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Koehler</surname>
<given-names>GJ</given-names></string-name>, <string-name><surname>Voss</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Hegemann</surname>
<given-names>JH</given-names></string-name></person-group>. <year>2002</year>. <article-title>A second set of loxP marker cassettes for Cre-mediated multiple gene knockouts in budding yeast</article-title>. <source>Nucleic Acids Res</source>
<volume>30</volume>:<elocation-id>e23</elocation-id>. doi:<pub-id pub-id-type="doi">10.1093/nar/30.6.e23</pub-id><pub-id pub-id-type="pmid">11884642</pub-id>
</mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Abolmaali</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Mitterbauer</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Spadiut</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Peruci</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Weindorfer</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Lucyshyn</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Ellersdorfer</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Lemmens</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Moll</surname>
<given-names>W-D</given-names></string-name>, <string-name><surname>Adam</surname>
<given-names>G</given-names></string-name></person-group>. <year>2008</year>. <article-title>Engineered bakers yeast as a sensitive bioassay indicator organism for the trichothecene toxin deoxynivalenol</article-title>. <source>J Microbiol Methods</source>
<volume>72</volume>:<fpage>306</fpage>&#x02013;<lpage>312</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mimet.2007.12.013</pub-id><pub-id pub-id-type="pmid">18243380</pub-id>
</mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Sauer</surname>
<given-names>B</given-names></string-name></person-group>. <year>1987</year>. <article-title>Functional expression of the cre-lox site-specific recombination system in the yeast Saccharomyces cerevisiae</article-title>. <source>Mol Cell Biol</source>
<volume>7</volume>:<fpage>2087</fpage>&#x02013;<lpage>2096</lpage>. doi:<pub-id pub-id-type="doi">10.1128/mcb.7.6.2087-2096.1987</pub-id><pub-id pub-id-type="pmid">3037344</pub-id>
</mixed-citation></ref></ref-list></back></article>